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Interference arises when the outcome of one individual depends on the treatment
status of another individual. Partial interference is a special case of interference where
individuals can be partitioned into groups such that no interference occurs between groups
but may occur within groups. In the absence of interference, inverse probability weighted
(IPW) estimators are commonly used to draw inference about causal effect. Tchetgen
Tchetgen and VanderWeele (2012) proposed a modified IPW estimator for different causal
effects in the presence of partial interference. An extension of the Tchetgen Tchetgen and
VanderWeele IPW estimator is proposed for the setting where the outcome is subject to
right censoring using inverse probability of censoring weights (IPCW). Censoring weights
are calculated using parametric frailty models. The large sample properties of the IPCW
estimators are derived and simulation studies are presented demonstrating the estimators’
performance in finite samples. The methods are illustrated using data from a cholera
vaccination trial in Matlab, Bangladesh.
Unfortunately, IPW methods often suffer from a significant disadvantage due to the
instability of propensity scores. The generalized computation algorithm formula (g for-
mula) is a natural alternative for IPW estimators. Robins (1986) proposed the use of
g-computation algorithm in the absence of interference to infer causal estimands of in-
terest. Since then, the parametric g formula has been used for data with time varying
confounding and exposure and also for time to event data (Robins 1987, Taubman et al.
2009, Westreich et al. 2012, Keil et al. 2014). An extension of the parametric g formula
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is proposed when there is time to event data with right censoring and possible partial
interference. Parametric frailty models are used to model the probability of an event.
Derivation of large sample properties of the estimator is provided. Simulation studies
show the operating characteristics of the method for finite samples. The cholera vacci-
nation trial in Matlab, Bangladesh is used to illustrate the methods in a real scenario.
But both of these methods rely on the intrinsic assumption that the underlying models
are correctly specified. If the treatment model is incorrect then the IPW/IPCW estima-
tor will be inconsistent. Similarly, if the outcome model is incorrect then the parametric
g formula will not be consistent. A doubly robust method is proposed to incorporate ro-
bustness under model misspecification so that the estimator is consistent even when only
one of the two models is correctly specified. Large sample properties of the estimator are
discussed. Finite sample performance of the method is also observed through simulation
and the results are compared with the IPW/IPCW and parametric g formula. Finally,
the doubly robust method is also applied to the cholera vaccine trial.
iv
ACKNOWLEDGEMENTS
This work was supported by NIH grant R01 AI085073. I would like to start by
thanking my dissertation committee members for their valuable input and support. In
particular, suggestions by Dr. Chirayath M. Suchindran and Dr. Stephen R. Cole about
time dependent censoring and parametric frailty models have been instrumental in my
project. I am also grateful to Dr. Jianwen Cai, especially for her recommendations on
the finite sample behavior of my estimates. Finally, I am also thankful to Dr. Michael
Emch for his comments that have made me appreciative about the implication of my
method on real data and in turn, have helped a great deal to interpret the results of my
work. Apart from my committee members, I would also like to thank Dr. M. Elizabeth
Halloran for her comments and suggestions on my first paper.
During the course of my research work, I have often found myself lost trying to tackle
problems both pertaining to my research work and my personal life. I am eternally
grateful to my adviser Dr. Michael G. Hudgens for always helping me through those
tough times. He has taught me a great deal about how to handle complex problems,
being methodical, and research work in general. I regard him as a great teacher and I
consider myself very fortunate to be one of his students. His unwavering motivation and
support have made my research possible. I sincerely thank him for his guidance.
I had the opportunity to be part of the Causal Inference with Interference (CIWI)
research group which has been a great experience. Suggestions of my group members
have often helped me make progress towards my goal. I would like to thank all CIWI
members: Brian Barkley, Bradley Saul, Wen Wei Loh, Shaina Mitchell, Kayla Kilpatrick,
and Bryan Blette for their contributions which have made research work a lot easier.
v
I would also like to thank my friends in North Carolina who have made my life here
easier and friends outside of North Carolina who have enriched my world. In particular,
to name a few, I am grateful towards Arkopal Choudhury, Arkaprava Roy, Aniket Bera,
Suman Chakraborty, Sujayam Saha, Debraj Das, Pratyaydipta Rudra, Sayan Banerjee,
Sayan Dasgupta, Abhishek Pal Majumder, Jyotishka Datta, Shalini Choudhury, Maxwell
Datta, Subhamay Saha, Sapna Rao, Anwesha Goswami, Rinku Majumder, and Samarpan
Majumder for always being there for me. I am thankful to Delilah for being in my life.
Last but not the least, I am forever grateful to Sohini Raha for her unending support,
constant enthusiasm, and for always guiding me through all the tough times that I
encountered.
Finally, I would like to dedicate my thesis to my parents, Shyamal and Gouri Chak-
ladar, my sister Soumita Das, and my nephew Shreyansh Das. I could not have managed
my journey without their support.
vi
TABLE OF CONTENTS
LIST OF TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . x
LIST OF FIGURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xi
CHAPTER 1: LITERATURE REVIEW . . . . . . . . . . . . . . . . . . . 1
1.1 Causal Inference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1.1 Inverse Probability Weighting . . . . . . . . . . . . . . . . . . . . 3
1.1.2 G Formula . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.1.3 Doubly Robust Estimator . . . . . . . . . . . . . . . . . . . . . . 4
1.2 Interference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.3 Censoring . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.4 Motivating Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
1.5 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
CHAPTER 2: CAUSAL INFERENCE WITH PARTIAL
INTERFERENCE AND RIGHT CENSORED OUTCOMES
USING IPCW ESTIMATORS . . . . . . . . . . . . . . . . . . . . . . . 14
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.2.1 Estimands . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.2.2 Assumptions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
2.2.3 Proposed Estimator . . . . . . . . . . . . . . . . . . . . . . . . . . 19
2.3 Simulation Study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2.4 Data Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
vii
2.4.1 Cholera Vaccine Study and Analysis . . . . . . . . . . . . . . . . 25
2.4.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
CHAPTER 3: PARAMETRIC G-FORMULA WITH PAR-
TIAL INTERFERENCE AND RIGHT CENSORING . . . . . . . . . 35
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.2.1 Estimands . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.2.2 Assumptions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.2.3 Proposed Estimator . . . . . . . . . . . . . . . . . . . . . . . . . . 40
3.3 Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
3.4 Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3.4.1 Cholera Vaccine Study and Analysis . . . . . . . . . . . . . . . . 48
3.4.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
3.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
CHAPTER 4: DOUBLY ROBUST ESTIMATION FOR
DATA WITH PARTIAL INTERFERENCE AND RIGHT
CENSORING . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
4.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
4.2.1 Estimands . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
4.2.2 Assumptions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
4.2.3 IPCW and Parametric G Formula Estimators . . . . . . . . . . . 64
4.2.4 Proposed Estimator . . . . . . . . . . . . . . . . . . . . . . . . . . 67
4.2.5 Properties of the Proposed Estimator . . . . . . . . . . . . . . . . 68
4.3 Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
4.4 Data Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
viii
4.4.1 Cholera Vaccine Study and Analysis . . . . . . . . . . . . . . . . 78
4.4.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
4.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
CHAPTER 5: CONCLUSION . . . . . . . . . . . . . . . . . . . . . . . . . 91
APPENDIX A: TECHNICAL DETAILS FOR CHAPTER 2 . . . . . . . 93
APPENDIX B: TECHNICAL DETAILS FOR CHAPTER 3 . . . . . . . 95
APPENDIX C: TECHNICAL DETAILS FOR CHAPTER 4 . . . . . . . 97
BIBLIOGRAPHY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
ix
LIST OF TABLES
2.1 Results from simulation study described in Section 2.3. α
denotes the allocation probability, µ(100, a, α) is the true
value of the target parameter for a = 0, 1; Bias is the aver-
age of µ(100, a, α)−µ̂(100, a, α) for a = 0, 1; ESE is the em-
pirical standard error; ASE is the average of the sandwich
variance estimates; and EC denotes the empirical coverage
of the 95% Wald confidence intervals. . . . . . . . . . . . . . . . . . . . . 34
3.1 Results from simulation study described in Section 3.3. α
denotes the allocation probabilities, µ(100, a, α) is the true
value of the survival probabilities at time point 100 for a =
0, 1; bias is the average of µ(100, a, α)−mint(100, a, α, ω̂),
ESE is the empirical standard error, ASE is the average
of the sandwich variance estimators and EC denotes the
empirical coverage of the 95% Wald type confidence intervals. . . . . . . 56
3.2 AIC (BIC) values for different baseline hazard functions
corresponding to gamma, inverse Gaussian and Positive
stable frailty distributions. . . . . . . . . . . . . . . . . . . . . . . . . . . 57
4.1 Results from simulation study described in Section 4.3. α
denotes the allocation probabilities, µ(100, a, α) is the true
value of the target parameter for a = 0, 1; Bias is the av-
erage of µ(100, a, α) − F̂DR(100, a, α) for a = 0, 1; ESE
is the empirical standard error, ASE is the average of the
sandwich variance estimates and EC denotes the empirical
coverage of the 95% Wald confidence intervals. . . . . . . . . . . . . . . . 89
4.2 AIC (BIC) values for different baseline hazard functions
corresponding to gamma, inverse Gaussian and positive
stable frailty distributions. . . . . . . . . . . . . . . . . . . . . . . . . . . 90
x
LIST OF FIGURES
2.1 Absolute bias (left) and 95% confidence interval coverage
(right) for different numbers of groups for α = 0.5. The
dotted line in the right plot corresponds to 95% coverage. . . . . . . . . . 31
2.2 Estimated cumulative probability of cholera over time for
vaccinated and unvaccinated for α = 0.3 (left), α = 0.45
(center) and α = 0.6 (right) . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.3 Direct, indirect, total and overall effect estimates (×1000)
for different allocation strategies at time t = 1 year. Indi-
rect, total, and overall effects are with respect to α2 = 0.4.
The shaded regions denote pointwise 95% confidence inter-
vals of the estimates. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
3.1 Estimated cumulative probability of cholera against time
for vaccine and control for α = 0.3 (left), α = 0.45 (center)
and α = 0.6 (right) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
3.2 Direct effect, indirect effect, total effect and overall effect
estimates multiplied by 1000 for different allocation strate-
gies at time t = 1 year. Indirect effects, total effects and
overall effects are with respect to α2 = 0.4. The shaded
region denotes the 95% confidence interval of the estimates. . . . . . . . . 55
4.1 Absolute biases of the doubly robust, parametric g and the
IPCW estimators under different model misspecifications
in control group. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
4.2 Absolute biases of the doubly robust, parametric g and the
IPCW estimators under different model misspecifications
in treatment group. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
4.3 Coverages of the doubly robust, parametric g and the IPCW
estimators under different model misspecifications in con-
trol group. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
4.4 Coverages of the doubly robust, parametric g and the IPCW
estimators under different model misspecifications in treat-
ment group. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
xi
4.5 Direct effect, indirect effect, total effect and overall effect
estimates multiplied by 1000 for different allocation strate-
gies at time t = 1 year. Indirect effects, total effects and
overall effects are with respect to α2 = 0.4. The shaded
region denotes the 95% confidence interval of the estimates. . . . . . . . . 88
xii
CHAPTER 1: LITERATURE REVIEW
1.1 Causal Inference
Association does not always imply causation. Causal inference aims to address causal-
ity in statistical inference. Splawa-Neyman et al. (1923) put forward the idea of potential
outcomes which has become a building block of causal inference. Potential outcomes or
counterfactual outcomes are defined to be all possible outcomes for a study which are
not necessarily observed and can be treated as missing data. For example, consider a
randomized clinical trial with a vaccine and a placebo. Then, the outcome when an indi-
vidual would be administered placebo is not observed if the individual was administered
treatment. This gives rise to the concept of potential outcomes or counterfactuals. In
terms of mathematics, denote by Yi (i = 1, . . . , n), the binary outcome of n individu-
als. Ai represents the binary treatment status of individual i. Ai equals zero if the i-th
individual receives placebo and equals one if said individual receives treatment. The
potential outcome for individual i under treatment a is denoted by Y ai . So, if individual i
receives placebo then Yi = Y 0i and Y 1i is unobserved and if individual i receives treatment
then Yi = Y 1i and Y 0i is unobserved. This is termed to be causal consistency formally
defined first in Gibbard and Harper (1976) and discussed in detail by Cole and Frangakis
(2009). Applications of this representation can be found in various literature including
(Haavelmo 1944, Robins and Greenland 1996, Pratt and Schlaifer 1988), epidemiology
(Greenland and Robins 1986, Robins et al. 2000; 1992, Robins 2000) social and behav-
ioral sciences (Sobel 1990; 1995, Willkinson 1999) and statistics (Rubin 2004, Pratt and
Schlaifer 1984).
Rubin (1974, 1977, 1978) defined various causal effects in terms of counterfactuals.
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For example, the average causal effect is defined as E(Y 1) − E(Y 0). He extended the
ideas for randomized experiments to non randomized studies. Most of the causal inference
framework assumes the Stable unit treatment value assumption (SUTVA) put forth by
Rubin (1980). The assumptions are-
1. There is no interference between individuals. That is, the treatment status of one
individual in no way affects the outcome of another individual. Mathematically Ai
has no effect on Yj if i 6= j.
2. There is only one version of treatment and control.
Along with SUTVA, in the case of a conditional randomized experiment or in an obser-
vational setting, it is often assumed that given a set of measured covariates, the potential
outcomes are independent of treatment. Denoting the set of measured confounders by L,
this assumption can be represented as Y a ⊥ A|L. This assumption is often referred to
as conditional exchangeability (Hernán and Robins (2006), Hernan and Robins (2010)).
Conditional exchangeability fails when there exist unmeasured covariates affecting both
the treatment and outcome. Hence this assumption is also known as no unmeasured
confounding. Another assumption that is often found in causal literature is the assump-
tion of positivity discussed by Westreich and Cole (2010). According to this assumption,
Pr(A = a|L = l) > 0 for a ∈ (0, 1) when Pr(L = l) > 0. i.e. if a particular value of the
covariates has a positive probability of being observed in the data then given that value
of the covariate, the probability of an individual being in the treatment as well as in he
control group must be positive. These assumptions are discussed in depth by Hernán
and Robins (2006). Under these assumptions, popular methods for estimating causal
effects for observational studies include inverse probability treatment weighted (IPTW)
estimator, parametric g formula and doubly robust estimator.
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1.1.1 Inverse Probability Weighting
The idea of inverse probability weighting revolves around creating a pseudo population
of individuals by weighting the study population with appropriate weights. The earliest
known use of these IPW type estimators were suggested by Horvitz and Thompson (1952).
These estimates have been used to estimate various causal effects like the average causal







The weight for individual i is I(Ai=a)
Pr(Ai=a|Li)
. The assumption of positivity ensures that
the term in the denominator Pr(Ai = a|Li) is greater than 0. Hence the estimator is
well defined. Here, Li is the vector of covariates for individual i. Under the assumptions
discussed previously, it has been shown to be an unbiased estimator of the causal quantity
of interest E(Y a) if Pr(Ai = a|Li) is known. The quantity Pr(Ai = a|Li) is termed
as the propensity score (Rosenbaum and Rubin 1983). So, for individuals receiving
treatment, in the estimation of E(Y 0), they are assigned zero weight. Whereas in the
estimation of E(Y 1), they are assigned the weight of the inverse of the probability that
they receive treatment given their individual covariates. However in an observational
setting, the propensity scores are seldom known beforehand. Rosenbaum and Rubin
(1983) suggested estimating the weights using a logit model. IPW estimators suffer from a
serious drawback. When the propensity score is close to zero, then the estimator becomes
large and computation becomes difficult (Little and Rubin 2014, Cole and Hernán 2008).
Inclusion of too many variables in the model might give rise to these problems. Certain
covariates might generate very low probability of treatment. This occurrence is sometimes
called narrow strata in the literature (Lefebvre et al. 2008).
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1.1.2 G Formula
The generalized computation algorithm formula (g formula) provides an alternative
way to compute causal effects and is free from the aforementioned drawback of IPW
estimators discussed in the previous section. Robins (1986) proposed the g formula to
estimate causal effects. Using parametric outcome regression models along with the g
formula gives rise to the parametric g formula. This method is a generalization of stan-
dardization (Hernán and Robins 2006). The assumptions discussed previously facilitate
writing E(Y a) as being equal to
´
E(Y |A = a,L = l)dFL(l). Again, the positivity
assumption ensures that the parameter is well defined. So, an estimate of this causal
quantity of interest Ê(Y a) is obtained by empirically estimating the distribution of L.





Ê(Y |A = a,Li)
Ê(Y |A = a,Li) is estimated using an outcome regression model. For example, in case
of a binary outcome, a logit model might be appropriate for modeling Y conditional on
A and L. Parametric g formula has been proven to be particularly useful in adjusting
for time varying confounders for time to event data (Young et al. 2011). Parameters of
interest such as risk ratio (Taubman et al. 2009, Garcia-Aymerich et al. 2013, Cole et al.
2013) and hazard ratio (Westreich et al. 2012, Keil et al. 2014) have been calculated using
this method. In all of these papers, pooled Logistic regression is the choice of parametric
outcome model.
1.1.3 Doubly Robust Estimator
Both the IPW estimator and the parametric g formula operate under the obvious
intrinsic condition that the underlying model is specified correctly. However, if the treat-
ment model is specified incorrectly then the IPW will produce erroneous results (Lefebvre
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et al. 2008, Cole and Hernán 2008). Similarly if the outcome model is specified incorrectly
then the estimates obtained using the parametric g formula can not be trusted (Taubman
et al. 2009). The doubly robust estimator incorporates robustness within the estimator
in the sense that the doubly robust estimator will generate reasonable results even when
only one of the treatment and outcome regression models are specified correctly. Doubly
robust estimators have existed in literature for sample survey data (Cassel et al. 1977,
Särndal et al. 2003). There have been a number of papers on doubly robust estimators
applied for the missing data problem and causal inference (Kang and Schafer 2007, Bang
and Robins 2005). Lunceford and Davidian (2004) put forth a doubly robust estimator
for estimating causal effects. The estimator proposed was a weighted combination of the
IPW estimator and the parametric g estimator. The estimator is as follows
Ẽ[Y 1] = n−1
n∑
i=1
AiYi − {Ai − P̂r(Ai = a|Li)}m̂1(Li)
P̂r(Ai = a|Li)
and
Ẽ[Y 0] = n−1
n∑
i=1
(1− Ai)Yi + {Ai − P̂r(Ai = a|Li)}m̂0(Li)
1− P̂r(Ai = a|Li)
where m̂a(Li) = Ê(Y |A = a,Li) The authors showed large sample results for the doubly
robust estimator. They showed that the estimate is consistent asymptotically normal
and they calculated large sample variance as well. The authors also showed the doubly
robust property of the estimate. Research is still ongoing for doubly robust estimators.
Cao et al. (2009) improved upon the doubly robust estimator. When both the models
are misspecified, doubly robust estimators give rise to significant biases. They also give
rise to biases for the case when the estimated propensity score becomes close to 0. The
authors tried to address this issue by modifying the existing doubly robust estimator and
showed that they perform better in the said situation. Funk et al. (2011) provides a good
theoretical and practical explanation of the properties of the doubly robust estimator for
causal outcomes of interest.
5
1.2 Interference
Interference is said to be present in a data when the the treatment status of one indi-
vidual affects the outcome of another individual (Cox 1958). An example of this might be
data on infectious diseases. In this setting, whether a person gets infected or not might
be affected by the treatment status of another individual (Halloran and Struchiner 1991).
Partial interference is a special case of interference. Partial interference occurs when we
have a partition of the data such that interference is observed within the individuals of a
group but not between the individuals in different groups (Sobel 2006). Data might show
traits of partial interference if there is a clear demographic separation between groups
of individuals based on geography, society, or temporality. Therefore, interference can
introduce possible indirect effects of interest which are termed spillover effects, or peer
effects. These effects have been discussed in various fields including criminology (Samp-
son 2010, Verbitsky-Savitz and Raudenbush 2012), developmental psychology (Duncan
et al. 2005, Foster 2010), econometrics (Sobel 2006, Manski 2013), education (Hong and
Raudenbush 2006, Vanderweele et al. 2013), imaging (Luo et al. 2012), political science
(Sinclair et al. 2012, Bowers et al. 2013), social media and network analysis (VanderWeele
and An 2013, Toulis and Kao 2013), (Eckles et al. 2014, Kramer et al. 2014), sociology
(Aronow and Samii 2017), and spatial analyses (Zigler et al. 2012, Graham et al. 2013).
Various literature propose methods for calculating interference effects in a randomized
setting (Rosenbaum 2007, Hudgens and Halloran 2008, Baird et al. 2018, Eckles et al.
2016). Hudgens and Halloran (2008) presented estimands of direct, indirect, total and
overall effects and proved the relations between them which was first discussed by Hallo-
ran and Struchiner (1991). Modifying previous notation, suppose data now has m groups
of individuals, with ni individuals per group for i = 1, . . . ,m. Denote by Aij, the indica-
tor of treatment status of individual j in group i i.e., if individual j in group i receives
treatment then Aij = 1 and otherwise Aij = 0. Also, let the vector of treatment indicator
of group i be denoted by Ai and that of group i except for individual j be denoted by
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Ai,−j. So, Ai = (Ai1, Ai2, ..., Aini) and Ai,−j = (Ai1, Ai2, ..., Aij−1, Aij+1..., Aini). Assume
that possible realizations of Ai and Ai,−j are denoted by ai and ai,−j respectively. The
outcome of individual j in group i is denoted by Yij (i = 1, . . . ,m, j = 1, . . . , ni). The
potential outcome for individual j in group i under treatment a for the individual and
treatment vector ai,−j for the rest of the individual in group i is denoted by Yij(a, ai,−j).
Since there are only two versions of treatments, if there are n individuals in a group,
then the set of all possible group treatment assignments consist of 2n elements and that
set is denoted by A(n) for n = 1, 2, . . .. The vector of covariates for subject j in group i
is denoted by Lij and the matrix of covariates for all subjects in group i is denote by Li,
i.e. Li = (Li1,Li2, · · · ,Lini). Hudgens and Halloran (2008) defined individual average










where α denotes the group allocation strategies (Hong and Raudenbush 2006, Sobel
2006, Tchetgen and VanderWeele 2012, Hudgens and Halloran 2008). Specifically, ac-
cording to the “Bernoulli" treatment allocation strategy discussed in Tchetgen Tchetgen
and Vanderweele (2012) α can be interpreted as the probability with which an individ-
ual receives treatment independently of others. Also, π(ai,−j, α) denote the conditional
probability that the treatment assignment for the ith group except for the jth individual
is ai,−j given that the jth individual in the ith group receives treatment a under alloca-
tion strategy α. In terms of probability, π(ai,−j, α) = Pr(Ai,−j = ai,−j|Ai,j = a). Then,
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π(ai,−j, α) = Π
ni
k=1,k 6=jα
aik(1−α)1−aik . Similarly, let π(ai, α) denote the conditional prob-
ability that the treatment assignment for the ith group is ai under allocation strategy α.
In terms of probability, π(ai, α) = Pr(Ai = ai). Then, π(ai, α) = Πnik=1α
aik(1 − α)1−aik .
The population average potential outcome is defined as















Then, according to Halloran and Struchiner (1995) and Hudgens and Halloran (2008)
the population average direct causal effect is a measure of the direct difference in effects
between vaccinated and unvaccinated individuals. It is given by µ(0, α) − µ(1, α). The
population average indirect casual effect is a measure of the herd spillover effect and is
the difference between the outcome of two unvaccinated individual under two different
allocation strategies. It is given by µ(0, α1)−µ(0, α2) for allocation strategies α1 and α2.
Population average total effect is a combination of both the direct and the indirect effects.
It is obtained by taking the difference between the population average potential outcome
of untreated individual at allocation level α1 and treated individuals at allocation level
α2, i.e. µ(0, α1)−µ(1, α2). Finally population average overall effect is obtained by taking
the difference between the average potential outcomes of individuals at allocation level
α1 and individuals at allocation level α2, i.e. µ(α1) − µ(α2). If there is no interference
present, then the direct effect would be equal to the total effect and the indirect effect
would be 0. A two stage stratified interference method is applied and unbiased estimates
of the parameters and also the variance estimator given the first stage of randomization
is obtained given various assumptions.
It is not possible to perform randomized experiments in all cases. For example, there
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might be ethical issues in implementing treatments selectively to randomized individuals.
Tchetgen Tchetgen and VanderWeele (TV) (2012) suggested using inverse probability
weighted (IPW) estimators for causal effects for observational data in such cases when
partial interference might be present within the data. The estimators were constructed
using group propensity scores instead of individual propensity scores. Perez-Heydrich
et al. (2014) and Liu et al. (2016) showed large sample properties of these estimates. The
estimate for the group level average potential outcome and marginal group level average
potential outcome are given respectively by















Using the estimators proposed by Tchetgen and VanderWeele (2012), Perez-Heydrich
et al. (2014) went on to calculate group propensity scores via modeling the probability of
participation using a mixed effects model. Using estimating equation representation and
results from Stefanski and Boos (2002), asymptotic variance estimators were calculated
and their estimators were given.
Liu et al. (2018) extends doubly robust estimators to the case with partial interference.
The form of the group average potential outcome estimate is as follows-











mij(a, ai,−j, Lij, β̂)π(ai,−j;α)]
Large sample properties of the estimator are also discussed.
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1.3 Censoring
In settings where the outcome of interest is survival time (e.g., time until infection),
the outcome is typically subject to (right) censoring due to study completion or par-
ticipant drop-out. Various semi parametric and parametric methods has been explored
in order to analyze clustered survival data. Glidden and Vittinghoff (2004) provides a
comparison of various methods of formulating the hazard function. Holt and Prentice
(1974) put forth a stratified Cox model with hazard function gij(.) having the following
form
gij(t|Lij) = g0i(t) exp (LTijγ),
where the group specific baseline hazards g0i(.) are completely unspecified. Multiple
failure times for a single subject, which can be interpreted as correlated survival data,
has also been analyzed using this method and the asymptotic properties of the estimator
have been provided (Wei et al. 1989). However, this did not facilitate between group
comparisons and Holt and Prentice (1974) suggested separate parameters to be estimated
for the different groups, i.e.,
gij(t|Lij) = ξig0(t) exp (LTijγ),
Specifically, the authors considered the model corresponding to g0(t) = 1 (exponential)
and g0(t) = tη−1. Pankratz et al. (2005) considered adding a random effect or frailty
term ei keeping the baseline hazard unspecified as follows
gij(t|Lij) = g0(t) exp (LTijγ + ei).
Their method made use of Laplace approximation for calculating the maximum likelihood
estimator for the general random effect proportional hazards model. Vaupel et al. (1979)
first used the term frailty in the context of mortality studies. Other methods used in
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the survival literature for analyzing correlated data use Bayesian techniques (Clayton
1991) like Gibbs sampling (Gauderman and Thomas 1994, Korsgaard et al. 1998), and
Monte-Carlo EM algorithm (Li and Thompson 1997); and frequentist approaches (Li and
Zhong 2002) like penalized likelihood maximization (Therneau et al. 2003).
Parametric frailty models have also been used to draw inference about right censored
correlated data (Lancaster 1979, Hougaard 1984). Gutierrez et al. (2002) gives a detailed
description of the various use of parametric frailty model in literature for analyzing right
censored data. The general form of the parametric frailty model is given by
gij(t|Lij, ei) = g0(λ, t)ei exp (LTijγ)
where g0 is the baseline hazard function, λ is the parameter of the baseline hazard
function, ei is a random component following density fe(ei; θr), t is the time to event
and γ is the vector of coefficients (Munda et al. 2012). The baseline hazard function is
assumed to have a parametric form. Various distributions like exponential, Weibull etc.
are used as the distribution of baseline hazard. The random component is known as the
frailty term.
Marginal structural models have been used for estimation of causal effects for right
censored data specifically for time dependent confounders (Robins et al. 2000). The pa-
rameters are typically obtained by IPW. For example, Hernán et al. (2000) used marginal
structural Cox proportional hazards model to estimate the effect of a time varying ex-
posure named zidovudine on the survival of HIV-positive men. Robins and Finkelstein
(2000) used inverse probability censoring weighted (IPCW) version of log rank test statis-
tic to show that bactrim therapy improved survival of AIDS patients. The IPCW method
has been rather popular for causal inference in right censored data (Cole and Hernán 2008,
Cain and Cole 2009, Howe et al. 2011).
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1.4 Motivating Data
A good motivating example for data with interference and right censoring is the
cholera vaccine study in Matlab from a cholera vaccine trial in Matlab, Bangladesh (Ali
et al. 2005). The data from this study were from children between the ages of 2 and
15 and women. The range of years through which data were collected was from 1985
to 1988. There were three available treatment groups and all the participants were
randomized to one of these three groups. These treatment groups are B subunit-killed
whole-cell oral cholera vaccine, killed whole-cell-only cholera vaccine and E. coli K12
placebo. The two vaccines were considered the same here for analysis purposes. The
inclusion of a participant was subject to the condition that the individual received two or
more doses of the vaccine. Non-participants were tracked using a vector of participation.
The participation vector comprised of indicators of participation fro each individual.
The vaccine and placebo were given from January 1985 to May 1985. Three centers
were set up in the Matlab area for administering the dosages and all centers were used
as surveillance centers as well. A total of 121,982 individuals were included. Perez-
Heydrich et al. (2014) have shown in their paper that interference is present. Related
individuals lived in clustered sets of houses called baris. There were a total of 6, 415
baris. Demographic separation was used to categorize all the baris in the study to different
groups (neighborhoods). The total number of these neighborhoods were prespecified to be
700. The assumption of partial interference treated these neighborhoods as groups such
that cholera can be transmitted from one individual to another within a neighborhood
but not between individuals of two separate neighborhoods. Studies discovered that the
probability of cholera among unvaccinated individuals was less for the neighborhoods
with higher vaccination coverage (Ali et al. 2005, Emch et al. 2006).
All of these studies have failed to adjust for censoring. The time of cholera is observed
only for a few individuals in the data and the rest are unobserved. The definition of
censoring, in this case, is if an individual did not observe an event within the study
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period, migrated elsewhere from the study location or died during the follow up period.
1.5 Summary
Methods for estimating various causal effects have been in the literature for random-
ized as well as observational studies under SUTVA. Some of these methods have been
extended for the case where the data show traits of partial interference. Methods have
been proposed for calculating various causal effects of interest when the data exhibit
right censoring. Three popular methods include the IPW method, parametric g formula,
and the doubly robust estimation method. This research aims at extending these ideas
towards the case when there is partial interference as well as right censoring. Section 2,
Section 3, and Section 4 explore corresponding methods using IPW, parametric g formula,
and doubly robust estimation, respectively. The methods are discussed and theoretical
results are given to show that the estimators are consistent and asymptotically normal.
Simulation studies are performed for all the three methods to demonstrate the efficacy of
the methods. All of these methods are applied to the Matlab cholera vaccination study
and the results are compared to previous research.
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CHAPTER 2: CAUSAL INFERENCE WITH PARTIAL
INTERFERENCE AND RIGHT CENSORED OUTCOMES USING
IPCW ESTIMATORS
2.1 Introduction
Interference arises when the outcome of one individual depends on the treatment sta-
tus of another individual (Cox 1958). For example, in the setting of infectious diseases,
whether one individual receives a vaccine may affect whether another individual becomes
infected (Halloran and Struchiner 1991). Partial interference is a special case of inter-
ference where individuals can be partitioned into groups such that interference does not
occur between individuals in different groups but may occur between individuals in the
same group (Sobel 2006). Partial interference might be a reasonable assumption if groups
of individuals are sufficiently separated geographically, socially, and/or temporally. Ef-
fects due to interference, also known as spillover effects or peer effects, are of interest
in many areas, including criminology (Sampson 2010, Verbitsky-Savitz and Raudenbush
2012), developmental psychology (Duncan et al. 2005, Foster 2010), econometrics (Sobel
2006, Manski 2013), education (Hong and Raudenbush 2006, Vanderweele et al. 2013),
imaging (Luo et al. 2012), political science (Sinclair et al. 2012, Bowers et al. 2013), social
media and network analysis (VanderWeele and An 2013, Toulis and Kao 2013, Kramer
et al. 2014, Eckles et al. 2014), sociology (Aronow and Samii 2017), and spatial analyses
(Zigler et al. 2012, Graham et al. 2013).
Inferential methods about spillover effects have been developed for randomized ex-
periments (Rosenbaum 2007, Hudgens and Halloran 2008, Eckles et al. 2016, Baird et al.
2018). However, in some settings it may not be feasible or ethical to randomize groups
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or individuals to different treatment or exposure conditions. In the observational setting,
Tchetgen Tchetgen and VanderWeele (henceforth TV) (2012) proposed inverse probabil-
ity weighted (IPW) estimators for different types of causal effects when there may be
partial interference. Large sample properties of these IPW estimators were considered
by Perez-Heydrich et al. (2014) and Liu et al. (2016).
In settings where the outcome of interest is a time to event, the outcome may be
subject to right censoring due to study completion or participant drop-out. In the absence
of interference, censoring is often accommodated by using inverse probability of censoring
weights along with inverse probability treatment weights (Robins et al. 2000, Hernán et al.
2000, Robins and Finkelstein 2000, Cole and Hernán 2008, Cain and Cole 2009, Howe
et al. 2011). In this section, an extension of the TV IPW estimators is considered for
the setting where there may be partial interference and the outcome is subject to right
censoring using inverse probability of censoring weights (IPCW).
The outline of this section is as follows. The proposed methods are developed in
Section 2.2. In Section 2.3 simulation results are presented demonstrating the empirical
performance of the proposed methods in finite sample settings. In Section 2.4 the meth-
ods are used to analyze a cholera vaccine study of over 90,000 individuals in Matlab,
Bangladesh. Section 2.5 concludes with a discussion.
2.2 Methods
2.2.1 Estimands
Suppose data are observed fromm groups of individuals, with ni individuals per group
for i = 1, . . . ,m. Let Aij = 1 if individual j in group i receives treatment and Aij = 0
otherwise. Let Ai = (Ai1, Ai2, ..., Aini) and Ai,−j = (Ai1, Ai2, ..., Aij−1, Aij+1..., Aini). Let
ai and ai,−j denote possible realizations of Ai and Ai,−j, and let A(n) denote the set of
all possible 2n treatments for a group size of n = 1, 2, . . .. Assume partial interference
and denote the potential time to event for individual j in group i if, possibly counter to
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fact, group i receives treatment ai by Tij(ai). The notation Tij(ai) reflects the partial
interference assumption, i.e., the potential outcome of individual j in group i does not
depend on the treatment of individuals outside group i. Below the notation Tij(a, ai,−j)
is sometimes used to make explicit the treatment for individual j and the treatment for
all other individuals in group i. Let Ti(.) = {Tij(ai) : ai ∈ A(ni), j = 1, 2, · · · , ni}
denote the set of all potential event times for individuals in group i. Suppose the event
times are subject to right censoring, e.g., due to loss to follow-up or study completion.
Let Cij denote the potential censoring times for individual j in group i. Assume that
treatment has no effect on the censoring times, i.e., Cij does not depend on ai. Let
∆ij = 1 if Tij(Ai) ≤ Cij and ∆ij = 0 otherwise, and let Xij = min(Tij(Ai), Cij). Define
Xi = (Xi1, Xi2, · · · , Xini) and ∆i = (∆i1,∆i2, · · · ,∆ini). Denote by Lij the vector of
baseline covariates for subject j in group i and by Li, the baseline matrix of covariates
for all subjects in group i, i.e., Li = (Li1,Li2, · · · ,Lini). The group sizes ni are assumed
to be random variables included in the baseline covariates Lij. Assume that them groups
are randomly sampled from an infinite superpopulation of groups such that the observed
data are m i.i.d. copies of Oi = (Li,Ai,Xi,∆i).
In the absence of interference, treatment effects are typically defined as contrasts in
mean potential outcome for different counterfactual scenarios, e.g., the average treatment
effect is usually defined as the difference in the mean potential outcomes had all individu-
als received treatment versus had no individuals received treatment. Similarly, in the set-
ting where there is partial interference, causal effects may be defined as contrasts in mean
potential outcomes for different counterfactual scenarios (Hong and Raudenbush 2006,
Sobel 2006, Hudgens and Halloran 2008, Tchetgen and VanderWeele 2012). Here we con-
sider counterfactual scenarios where the marginal probability that an individual receives
treatment, Prα(Aij = 1), equals α for different values of α ∈ (0, 1). The notation Prα(·)
indicates that the probability corresponds to the distribution under the counterfactual
scenario. Specifically, we consider the Bernoulli treatment allocation strategy (or policy)
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described in TV is considered wherein individuals independently select treatment with
probability α. Let π(ai, α) denote the probability that group i receives treatment ai under








The causal estimands of interest defined below are contrasts in the risk of having an
event by time t for different combinations of treatment a and allocation strategies α. To
define these estimands, let
F̄ij(t, a, α) =
∑
ai,−j∈A(ni−1)





I{Tij(ai) ≤ t}π(ai, α).
In words, F̄ij(t, a, α) is the probability that individual j in group i will have an event
by time t when receiving treatment a and the group adopts policy α. Likewise, F̄ij(t, α)
is the probability that individual j in group i will have an event by time t when the
group adopts allocation strategy α. Denote the group average risks by F̄i(t, a, α) =
n−1i
∑ni




j=1 F̄ij(t, α). Let µ(t, a, α) = Eα{F̄i(t, a, α)}
and µ(t, α) = Eα{F̄i(t, α)} where Eα{.} denotes the expected value under the counterfac-
tual setting when policy α is adopted in the super population of groups. In the cholera
vaccine study described in Section 2.4, µ(t, a, α) denotes the average risk of acquiring
cholera by time t when an individual receives treatment a and other individuals receive
vaccine with probability α. Various effects of treatment can be defined by contrasts in
µ(t, a, α) and µ(t, α). The direct effect is obtained by comparing the probability of an
event when an individual receives treatment versus when not receiving treatment for a
fixed allocation strategy. In particular, the direct effect at time t corresponding to policy
α is defined to be DE(t, α) = µ(t, 0, α) − µ(t, 1, α). The indirect (or spillover) effect
is the difference in the probability of an event by time t for two different policies when
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the individual does not receive treatment. Specifically, the indirect effect is given by
IE(t, α1, α2) = µ(t, 0, α1) − µ(t, 0, α2) for allocation strategies α1 and α2. An indirect
effect can analogously be defined when an individual is vaccinated. The total effect is
defined as the difference between the probability of an event by time t when an individual
does not receive treatment under policy α1 and when an individual receives treatment
under policy α2, i.e., TE(t, α1, α2) = µ(t, 0, α1)− µ(t, 1, α2). Finally, the overall effect is
the difference between the probability of an event by time t for policy α1 versus α2, i.e.,
OE(t, α1, α2) = µ(t, α1)− µ(t, α2).
2.2.2 Assumptions
Assume the following for all ai ∈ A(ni),
I) Conditional independence: Ai ⊥ Ti(.)|Li,
II) Positivity: Pr(Ai = ai|Li = l) > 0 for all ai ∈ A(ni) and l such that Pr(Li = l) > 0,
III) Conditional independent censoring: Ci ⊥ {Ti(.),Ai}|Li.
Assumption I states that the potential event times for individuals within the same
group are conditionally independent of the actual treatment received by the group given
covariates; this is a group-level generalization of the usual individual-level no unmeasured
confounders assumption often made in the absence of interference. Positivity assumes
that each group has a non-zero probability of being assigned every possible treatment
combination given covariates for the group. Assumption III states that the potential
event times for individuals in the same group and the observed group treatment are
conditionally independent of the censoring times given covariates. It is straightforward
to adapt the methods below to allow for a weaker version of assumption III whereby




In the absence of censoring, the IPW estimator proposed by TV can be used to draw
inference about µ(t, a, α) and µ(t, α). In particular, letting Yij = I(Xij ≤ t), the TV IPW

























and β̂ is an estimator of the vector of parameters for the propensity model Pr(Ai|Li,β).
Details of the propensity model are discussed in the next sections.
In the presence of censoring, the following extension of the TV IPW estimators is
proposed: µ̂(t, a, α) = m−1
∑m
i=1 F̂i(t, a, α) and µ̂(t, α) = m
−1∑m
i=1 F̂i(t, α) where





π(Ai,−j;α)I(Aij = a)I(∆ij = 1)I(Xij ≤ t)
Pr(Ai|Li, β̂) Pr(∆ij = 1|Li, Xij, γ̂)
,





π(Ai;α)I(∆ij = 1)I(Xij ≤ t)
Pr(Ai|Li, β̂) Pr(∆ij = 1|Li, Xij, γ̂)
,
and γ̂ is an estimator of the vector of the parameters for the censoring model. De-
tails of the censoring model are discussed in the next sections. Estimates of the di-
rect, indirect, total, and overall effects are given by D̂E(t, α) = µ̂(t, 0, α) − µ̂(t, 1, α),
ÎE(t, α1, α2) = µ̂(t, 0, α1) − µ̂(t, 0, α2), T̂E(t, α1, α2) = µ̂(t, 0, α1) − µ̂(t, 1, α2) and
ÔE(t, α1, α2) = µ̂(t, α1)− µ̂(t, α2).
Known Treatment and Censoring Distributions
The proposition below shows that if the group level propensity scores and the individual
censoring probabilities are known, then the proposed IPCW estimators are unbiased. A
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proof of the proposition is given in Section 2.6.
Proposition 1. If Pr(Ai|Li) and Pr(∆ij = 1|Li) are known for all j = 1, 2, . . . , ni, then
E{F̂i(t, a, α)} = F̄i(t, a, α) and E{F̂i(t, α)} = F̄i(t, α).
Unknown Treatment and Censoring Distributions
In observational studies, neither the conditional distribution of treatment given covariates
nor the conditional distribution of censoring given covariates are known. Therefore, we
consider finite dimensional parametric models to estimate the group propensity scores
and conditional probability of censoring; these estimates are then plugged into the IPCW
estimators defined above. The conditional probability of censoring is estimated using a
frailty model (Munda et al. 2012) where the conditional hazard for Cij is assumed to
have the form gij(c|Lij, ei) = g0(c;θh)ei exp (LTijθc), where g0 is the baseline hazard
function, θh is the q′- dimensional parameter vector of the baseline hazard function, ei is
a random effect with density fe(ei; θr), and θc is the q-dimensional vector of coefficients.
Let γ = (θc,θh, θr) be the vector of parameters for the frailty model. Maximum likelihood
theory can be used to draw inference about γ. Under assumption III, the contribution




















g0(κ)dκ, and L(s) is the s-th derivative of the Laplace transform of the frailty
distribution, i.e., L(s) =
´∞
0
exp (−eis)fe(ei; θr)dei. Therefore, the maximum likelihood
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estimator of γ solves the following estimating equations
∑
i
ψck(Xi,∆i,Li,γ) = 0 for k = 1, ..., q + q′ + 1,
where ψck = ψck(Xi,∆i,Li,γ) = ∂l(Xi,∆i,Li,γ)/∂γk and γk is the k-th element of γ.
Below, the baseline hazard for the censoring model is assumed to be constant and
equal to θh such that gij(c|Lij, ei) = θh exp (Lijθc)ei. In addition, the frailty term ei is
assumed to follow a gamma distribution with mean 1 and variance θr. So, the censoring
weight for an uncensored individual equals
Pr(∆ij = 1|Li,γ) =
ˆ
Pr(Cij > Tij(Ai)|Li,γ, ei)fe(ei; θr)dei
=
ˆ
Pr(Cij > Xij|Li,γ, ei)fe(ei; θr)dei
=
ˆ












θrθhXij exp (Lijθc) + 1
}1/θr
Following TV (2012), a mixed effects model may be assumed for the treatment allocation,
i.e., Pr(Aij = 1|Lij, bi) = logit−1(Lijθx + bi) where bi is a random effect following density
fb(bi; θs). (In the application below the mixed effects model has a slightly more compli-
cated form owing the particulars of the design of the study analyzed.) Let β = (θx, θs)
denote the (p+ 1) dimensional vector of parameters for the mixed effects model. Again,
maximum likelihood theory can be used to draw The contribution of group i to the








where hij(bi,Li,β) = Pr(Aij = 1|Lij, bi). The maximum likelihood estimator of β is the
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solution to the score equations
∑
i
ψxk(Ai,Li,β) = 0 for k = 1, ..., p+ 1,
where ψxk = ψxk(Ai,Li,β) = ∂l(Ai,Li,β)/∂βk, βk is the k-th element of β.
Inference about the causal effects of interest is then based on solving the vector of
estimating equations ∑
i
ψ(Oi,θ) = 0, (2.1)
where θ = (γ,β, θ), ψ(Oi,θ) = (ψc,ψx, ψaα)
T , ψc = (ψc1, ψc2, ..., ψcq+q′+1)
T , ψx =
(ψx1, ψx2, ..., ψxp+1)
T ,










π(Ai,−j;α)I(Aij = a)I(Xij ≤ t)
Pr(∆ij = 1|Lij, Xij,γ)
.
Let θ̂ = (γ̂, β̂, µ̂(t, a, α)) denote the solution to (1). Denote the true value of θ by
θ0 = (γ0,β0, µ(t, a, α)) and note that
ˆ




− µ(t, a, α)
}
= 0,
where FO denotes the joint distribution of the complete observed random variable O
and the last equality follow from the Proposition above. Therefore, assuming the
parametric models above are correctly specified, it follows that
´
ψ(o,θ0)dFO(o) =
0. By M-estimation theory (Stefanski and Boos 2002), θ̂ p→ θ0 and
√
m(θ̂ − θ0)
converges in distribution to a Normal distribution with mean 0 and covariance ma-
trix Σ equal to U(θ0)−1V (θ0){U(θ0)−1}T where U(θ0) = E{−ψ̇(Oi,θ0)}, V (θ0) =
E{ψ(Oi,θ0)ψ(Oi,θ0)T}, and ψ̇(Oi,θ) = ∂ψ(Oi,θ)/∂θT . Consistency and asymptotic
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normality of the direct, indirect and total effect estimators follows from the delta method.
Similar techniques can be used to show that µ̂(t, α) and the overall effect estimator are
also consistent and asymptotically Normal. The asymptotic variance Σ can be consis-
tently estimated by Σ̂ = Û(θ̂)−1V̂ (θ̂){Û(θ̂)−1}T where Û(θ̂) = m−1
∑m
i=1{−ψ̇(Oi, θ̂)}
and V̂ (θ̂) = m−1
∑m
i=1{ψ(Oi, θ̂)ψ(Oi, θ̂)T}. The empirical sandwich variance estimator
Σ̂ can be computed using the R package geex (Saul and Hudgens 2017) and can be used
to construct Wald type confidence intervals (CIs).
2.3 Simulation Study
A simulation study was conducted to assess the finite sample bias of the IPCW esti-
mator and coverage of the corresponding Wald confidence intervals. The data generating
model used in the simulation study was motivated by aspects of the cholera vaccine study
analysis presented in the next section. Following Perez-Heydrich et al. (2014), data were
simulated according to the following steps.
i) First, two baseline covariates L1ij and L2ij were randomly generated. In the ap-
plication presented in Section 2.4, conditional exchangeability is assumed given an
individual’s age (in decades) and the distance of their residence to the nearest river.
Motivated by this example, L1ij and L2ij were randomly generated as follows. First,
Vij was randomly generated from an exponential distribution with mean 20. Then
L1ij was set to min(Vij, 100)/10. The second set of covariates L2ij were randomly
sampled such that logL2ij ∼ normal(0, 0.75).
ii) The random effects for the treatment model bi were randomly sampled from a normal
distribution with mean 0 and variance 0.0859.
iii) The treatment indicators Aij were randomly sampled from a Bernoulli distribution
with mean pij = expit(0.2727− 0.0387L1ij + 0.2179L2ij + bi).
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iv) The potential times to event Tij(ai) were randomly sampled from an exponential
distribution with mean µij = 200 + 100aij − 0.98L1ij − 0.145L2ij + 50
∑
k 6=j aik/ni.
v) The random effects for the censoring model ei were randomly generated from a
gamma distribution with mean 1 and variance θ = 1.25.
vi) Censoring times Cij were randomly sampled from an exponential distribution with
mean 1/λ0 where λ0 = 0.015 exp (0.002L1ij + 0.015L2ij)ei.
vii) Individual censoring indicators were determined i.e., ∆ij = 0 if Cij < Tij(Ai).
Steps i through vii were used to stochastically generate 1000 data sets, with each data
set containing 500 groups with 10 individuals per group. For each simulated data set,
the IPCW estimator of µ(100, a, α) was evaluated for a = 0, 1 and α = 0.1, 0.2, . . . , 0.9.
Estimated standard errors based on the empirical sandwich variance estimator and Wald
95% confidence intervals were also calculated for each simulated data set. Empirical
standard errors were calculated by taking the standard deviation of the point estimates
from all simulations.
The true value of the estimand was obtained by simulating counterfactual outcomes
form = 106 groups of individuals. Note that, according to the model used to generate the
data, potential survival times depend only on
∑
k 6=j aik. So, µ(t, a, α) was approximated













I{Tij(a, k) ≤ t}αk(1− α)ni−k−1.
The true value of µ(t, α) was determined in a similar fashion.
Results from the simulation study are presented in Table 2.1. Bias of the IPCW
estimator was negligible for all values of a and α. Likewise, the average estimated stan-
dard error was close to the empirical standard error. Coverage of the 95% Wald CIs was
approximately equal to the nominal level.
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Additional simulation studies were conducted to assess the performance of the pro-
posed methods for different values of m, the total number of groups, ranging from 10
to 500. The number of individuals per group was 10, as in the previous simulations.
For each m ∈ {10, 50, 100, 200, 300, 400, 500}, 1000 data sets were simulated according to
steps i through vii above. Results are depicted in Figure 2.1. Bias of the IPCW estimator
was small and coverage of the Wald CIs was close to the nominal level provided m was
at least 50.
2.4 Data Analysis
2.4.1 Cholera Vaccine Study and Analysis
In this section, the methods described in Section 2.2 are used to analyze a cholera
vaccine study in Matlab, Bangladesh (Ali et al. 2005). Eligible study participants were
children 2–15 years of age and women greater than 15 years old. All 121, 975 eligible
individuals in the population were randomized to one of three vaccination groups: B
subunit-killed whole-cell oral cholera vaccine, killed whole-cell-only cholera vaccine, and
E. coli K12 placebo. As in Perez-Heydrich et al. (2014), no distinction is made between
the two vaccines in the analysis presented here. Individuals were considered to have
participated in the randomized trial component of the study if they received two or more
doses of vaccine or placebo. The primary endpoint of the trial was incident cholera. Three
health centers in the Matlab area served as surveillance centers and collected endpoint
data on all individuals, regardless of whether they participated in the randomized trial.
The analysis presented here includes data from all individuals, i.e., trial participants as
well as those who chose not to participate. Thus an approach which accounts for possible
confounding, such as the IPW method described in Section 2, should be utilized to assess
the effects of vaccination.
Previous analyses of this study suggest the presence of interference (Ali et al. 2005,
Perez-Heydrich et al. 2014). However, these previous analyses did not formally account
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for censoring. Here individuals are considered right censored if they were not diagnosed
with cholera during the study. Individuals who emigrated from the study location or died
during the follow-up period prior to cholera infection were right censored at the time of
emigration or death. Individuals who did not emigrate or die and who did not develop
cholera during the study were right censored at the end of the study period.
Related individuals in Matlab live in clustered sets of houses called baris. There were
a total of 6,415 baris at the time of the vaccine trial. Perez-Heydrich et al. (2014) used
a clustering algorithm to form groups (neighborhoods) based on the spatial location of
the baris, with the number of groups pre-specified to be 700. The analysis here is based
on the same groups as in Perez-Heydrich et al. and assumes that there is no interference
between individuals in different groups, i.e, the vaccination of an individual in one group
has no effect on whether an individual in another group acquires cholera. When fitting
the propensity model Pr(Ai|Li,β) described below, the largest 15 groups had estimated
group propensity scores that were effectively equal to zero and therefore these groups
were omitted.
Individuals participating in the vaccine trial were not all vaccinated on the same
calendar day, such that the level of vaccine coverage within a group varied over a relatively
brief period of calendar time at the study onset. For simplicity and because the methods
developed above do not accommodate time varying treatment, the start of follow-up
for all individuals in a particular group was set to the latest date of second vaccination
among all individuals in that group. Some observations were excluded because individuals
contracted cholera, died, or emigrated prior to the start of follow-up for their group.
In total, 94,234 individuals were included in the analysis. Among these individuals,
55,413 were unvaccinated, either because they received placebo or they did not partici-
pate, and 38,821 were vaccinated with one of the two vaccines. During follow-up, there
were 280 incident cases of cholera among the unvaccinated individuals and 74 cholera
cases among the vaccinated individuals.
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As in Perez-Heydrich et al., the group propensity score was modeled using a mixed
effects model. The particular form of the model derives from the fact that in order for an
individual to have received a vaccine, they must have (i) chosen to participate in the trial,
and (ii) been randomized to receive one of the two vaccines. To account for (i), a logistic
regression model for participation was assumed. As in Perez-Heydrich et al., covariates in
the participation component of the model were age, squared age, distance to nearest river,
and squared distance to nearest river. Accommodating (ii) in the propensity model is
straightforward because, due to randomization, individuals who elected to participate in
the trial were known to receive one of the two vaccines with probability 2/3. Combining






where hij(bi,Li,θx) = Pr(Bij = 1|bi,Lij,θx) = expit(Lijθx + bi), Bij is the indicator
of participation, i.e., Bij = 1 if individual j in group i participated in the randomized
trial and Bij = 0 otherwise, and (θ̂x, θ̂s) is the maximum likelihood estimate of (θx, θs).
Censoring was modeled using the gamma frailty model described above, and only included
age as covariate as no other variables were associated with censoring. Over 70% of
individuals belonged to groups where the vaccine coverage was between 0.3 and 0.6.
Therefore, the analysis was conducted for allocation strategies ranging from 0.3 to 0.6.
2.4.2 Results
Figure 2.2 shows the IPCW estimates of the cumulative probability of cholera over
time for allocation strategies 0.3, 0.45, and 0.6, both when an individual receives a
vaccine and when an individual is unvaccinated. The estimated risk of cholera when an
individual is unvaccinated decreases dramatically as α increases, suggesting the presence
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of interference. This decrease is more modest when an individual is vaccinated, indicating
a stronger indirect effect when unvaccinated. At all time points the estimated risk of
cholera is higher when an individual is unvaccinated, suggesting a beneficial, direct effect
of vaccination, especially at lower coverage levels. For α = 0.3 and α = 0.45, the
estimated risk when unvaccinated increases suddenly between 200 and 300 days, and
then again between 300 and 400 days. These results might be attributable to the known
bimodal seasonality of cholera in Bangladesh (Longini et al. 2002). Note that, because
the study start date varied across groups, the time scale in this analysis does not exactly
coincide with calendar time. Nonetheless, 95% of individuals had a start date within a
two calendar month range, such that there is a strong correlation between the analysis
time scale and calendar time, and thus cholera seasonality may explain these periods of
marked increase in risk.
Direct, indirect, total and overall effect estimates and 95% CIs (×1000) for differ-
ent allocation strategies at time t = 1 year are shown in Figure 2.3. The direct effect
estimates generally decrease as α increases. For example, the direct effect estimate for
α = 0.35 is 3.6 (95% CI 1.1, 6.2) whereas for α = 0.5 the direct effect estimate is 1.5 (95%
CI −0.5, 3.5). The indirect, total, and overall effect estimates in Figure 2.3 compare the
risk of cholera over a range of allocation probabilities α1 ∈ [0.3, 0.6] versus α2 = 0.4.
Here the indirect effect contrasts risk of cholera infection when individuals are unvac-
cinated. For larger values of α1 the 95% CIs for these effects exclude the null value of
zero. For example, for α1 = 0.6 the indirect effect estimate is 2.8 (95% CI 1.1, 4.5),
providing statistical evidence of the presence of interference. These results indicate that
when individuals are unvaccinated, the risk of cholera infection is significantly reduced
by increasing the level of vaccine coverage in their neighborhood. The total effect esti-
mates quantify the combined direct and indirect effects of the vaccine. The overall effect
estimates may be of greatest interest from a public health or policy perspective. For
α1 = 0.6, the overall effect estimate is 2.2 (95% CI 0.9, 3.4); in words, 2.2 fewer cases of
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cholera per 1000 individuals per year are expected if 60% of individuals are vaccinated
compared to if only 40% of individuals receive vaccine.
In previous analyses of these data, Perez-Heydrich et al. also estimated the direct,
indirect, total and overall effects using a binary outcome indicating whether an individual
was infected with cholera during the first year of follow-up. The IPCW estimates for t = 1
are similar to these previous results, e.g., Perez-Heydrich et al. estimated the direct effect
for alpha=0.32 to be 5.3 (95% CI 2.5, 8.1) whereas the IPCW estimate of this effect at
t = 1 is 4.0 (95% CI 1.6, 6.5). However,the Perez-Heydrich et al. estimates may be biased
because they did not account for right censoring.
2.5 Discussion
In this section, the TV IPW estimator for partial interference was extended to allow
for right censored outcomes. The proposed estimator was obtained by weighting the
original TV estimator by censoring weights calculated from a parametric frailty model
of the censoring times. The estimator was shown to be consistent and asymptotically
normal and a consistent estimator of the asymptotic variance was proposed. A simulation
study demonstrated that the proposed methods performed well in finite samples provided
the number of groups is sufficiently large. Analysis of a cholera vaccine study using the
proposed methods suggests vaccination had both a direct and indirect effect against
cholera infection. These results are in accordance with findings by Ali et al. (2005) and
Perez-Heydrich et al. (2014), but are likely more accurate since these previous analyses
did not formally account for right censoring.
There are several areas of possible future research related to the methods developed
here. For example, further research could entail developing estimators which perform
well in settings where the number of groups is small. Alternative IPCW estimators
could be developed which utilize semi-parametric frailty models to estimate the censoring
weights rather than the fully-parametric models employed here. Extensions of the IPCW
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estimator could also be considered for the setting where there is general interference, i.e.,
where interference is not restricted to individuals within the same group. In this paper
only Horwitz-Thompson type IPCW estimators were considered; further research could
entail developing stabilized or Hajek type IPCW estimators which may be more stable
and less variable. Finally, simulations studies (results not shown here) suggest that the
proposed IPCW estimators may be sensitive to model mis-specification. Future research
could entail developing estimators that are robust to model mis-specification, perhaps
by constructing doubly robust estimators which utilize both a treatment model and an
outcome model.
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Figure 2.1: Absolute bias (left) and 95% confidence interval coverage (right) for different
numbers of groups for α = 0.5. The dotted line in the right plot corresponds to 95%
coverage.










































Figure 2.2: Estimated cumulative probability of cholera over time for vaccinated and































































Figure 2.3: Direct, indirect, total and overall effect estimates (×1000) for different allo-
cation strategies at time t = 1 year. Indirect, total, and overall effects are with respect to
α2 = 0.4. The shaded regions denote pointwise 95% confidence intervals of the estimates.
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α µ(100, 0, α) Bias ESE ASE EC α µ(100, 1, α) Bias ESE ASE EC
0.1 0.39 0.02 0.07 0.07 94% 0.1 0.28 0.01 0.08 0.08 92%
0.2 0.38 0.01 0.04 0.04 96% 0.2 0.27 0.01 0.04 0.04 95%
0.3 0.38 0.00 0.03 0.03 96% 0.3 0.27 -0.00 0.03 0.03 95%
0.4 0.37 -0.00 0.03 0.02 95% 0.4 0.27 -0.01 0.02 0.02 94%
0.5 0.36 -0.00 0.03 0.02 94% 0.5 0.26 -0.00 0.02 0.02 93%
0.6 0.36 -0.01 0.03 0.02 94% 0.6 0.26 -0.00 0.02 0.02 93%
0.7 0.35 -0.00 0.03 0.02 94% 0.7 0.26 -0.01 0.02 0.01 94%
0.8 0.35 -0.01 0.03 0.03 94% 0.8 0.25 -0.00 0.02 0.02 93%
0.9 0.34 -0.00 0.05 0.05 92% 0.9 0.25 0.01 0.02 0.02 95%
Table 2.1: Results from simulation study described in Section 2.3. α denotes the alloca-
tion probability, µ(100, a, α) is the true value of the target parameter for a = 0, 1; Bias is
the average of µ(100, a, α)− µ̂(100, a, α) for a = 0, 1; ESE is the empirical standard error;
ASE is the average of the sandwich variance estimates; and EC denotes the empirical
coverage of the 95% Wald confidence intervals.
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CHAPTER 3: PARAMETRIC G-FORMULA WITH PARTIAL
INTERFERENCE AND RIGHT CENSORING
3.1 Introduction
Interference is present when the outcome of one individual depends on the treatment
status of another individual (Cox 1958). An example of this might be data on infectious
diseases. For these types of data, whether a subject becomes infected or not might be
affected by the vaccination status of another individual (Halloran and Struchiner 1991).
Sobel (2006) introduces the notion of partial interference as a subset of interference. If
individuals can be partitioned into groups such that interference can occur within individ-
uals of one group but it cannot occur between individuals from two separate groups, the
data is said to show traits of partial interference. Well defined social, temporal, and/or
geographical difference between groups of people might be a valid reason for assuming
they have partial interference. Interference might produce effects termed spillover effects
or peer effects, which are of importance for various different fields of study.
There are inference methods available for randomized experiments in the presence of
interference (e.g., Rosenbaum 2007, Hudgens and Halloran 2008, Baird et al 2014, Eckles
et al 2016). But it might not always be possible to conduct randomized experiments due
to feasibility and/or ethical issues. Tchetgen Tchetgen and VanderWeele (TV) (2012)
provided consistent estimates for various causal effects in the absence of randomization
i.e. for observational data using inverse probability weighting. However, there are some
significant disadvantages of using IPW estimators. For example, a propensity score close
to zero might make the estimator unstable and difficult to calculate computationally. A
substitute of the inverse probability weighted estimator to calculate causal effects is to use
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the parametric g formula. The generalized computation algorithm formula (g formula)
was first put forward by Robins (1986). G-formula, together with outcome regression
produces the parametric g formula. The theory of parametric g formula is generalized
from standardization (Hernán and Robins 2006). Parametric g formula has been used
mainly in adjusting for time varying confounders for time to event data (Young et al.
(2011)). Many authors used parametric g formula to calculate risk ratio (Taubman et al.
(2009), Garcia-Aymerich et al. (2013), Cole et al. (2013)) and hazard ratio (Westreich
et al. (2012), Keil et al. (2014)). However, all of the authors have used logistic regression
for modeling the probability of outcome.
The rest of the section is organized as follows. Section 3.2 introduces the estimators
and estimands. Results from simulation studies illustrating the finite sample behavior of
the method are presented in Section 3.3. The proposed method is implemented on a real
data consisting of 100,000 individuals in Matlab, Bangladesh in Section 3.4.
3.2 Methods
3.2.1 Estimands
Assume that there are m groups, each group having ni individuals in them for
i = 1, . . . ,m. Depending on whether individual j in group i gets treatment or
placebo, denote Aij = 1 or Aij = 0 respectively. Let Ai = (Ai1, Ai2, ..., Aini) and
Ai,−j = (Ai1, Ai2, ..., Aij−1, Aij+1..., Aini) denote the overall group treatment assignment
and the group treatment assignment without individual j for group i respectively. Also,
let Ai and Ai,−j attain possible values ai and ai,−j respectively. The potential time to
event for individual j in group i with treatment ai is denoted by Tij(ai). These potential
times exhibit traits of partial interference in the sense that the potential time to event
Tij(ai) for individual j in group i might be dependent on the treatment status of indi-
vidual j′ in group i even when j′ does not equal j. However, if i 6= i′, then Tij(ai) is
independent of Ai′j for any j. The set of all potential event times for individuals in group
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i is denoted by Ti(.) = {Tij(ai) : ai ∈ A(ni), j = 1, 2, · · · , ni}. Assume that there is right
censoring within the time to events. Also assume that Cij are censoring time for individ-
ual j in group i. Let ∆ij = I(Tij(Ai) ≤ Cij) and Xij = min(Tij(Ai), Cij). Then ∆ij is
the censoring indicator and Xij is the observed time to event for individual j in group i.
The vector of censoring indicators for group i denoted by ∆i equals (∆i1,∆i2, · · · ,∆ini)
and the vector of observed time to events denoted by Xi equals (Xi1, Xi2, · · · , Xini). The
set of every feasible 2n assignments of treatments for n = 1, 2, . . . is denoted by A(n).
Finally, the vector of all the covariates for subject j in group i is termed as Lij and
Li = (Li1,Li2, · · · ,Lini) denotes the matrix of covariates for group i. Let the baseline
covariates Lij include group sizes ni. The m groups in data is assumed to be sampled
from an infinite superpopulation of groups and the m observations (Li,Ai,Xi,∆i) are
i.i.d..
When there is no possible interference, there is often interest in finding the average
treatment effect. This can be represented as the difference between two counterfactual
outcomes, the first one being the case where all the individuals in the population are
treated and the second one being the case when no individual in the population are
treated. But if interference is present in a data then the group allocation strategies α
might affect the counterfactual outcomes of interest (Hong and Raudenbush 2006, Sobel
2006, Tchetgen and VanderWeele 2012, Hudgens and Halloran 2008). Tchetgen Tchetgen
and Vanderweele (2012) discussed how α can be explained as a “Bernoulli" treatment
allocation strategy. A possible interpretation of α might be the probability of being
assigned treatment independent of others for an individual. Hence, a natural extrap-
olation of the concept of average treatment effect might be calculating the difference
between the counterfactual outcomes corresponding to two different levels of allocation
strategies α and α′. Again, let the conditional probability that the treatment assignment
for group i except for individual j is ai,−j given that the jth individual in the ith group
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receives treatment a under allocation strategy α be denoted by π(ai,−j, α). Mathemat-
ically, this can be denoted as follows π(ai,−j, α) = Pr(Ai,−j = ai,−j|Ai,j = a). Then,
π(ai,−j, α) = Π
ni
k=1,k 6=jα
aik(1−α)1−aik . Similarly, let π(ai, α) denote the conditional prob-
ability that the treatment assignment for the ith group is ai under allocation strategy
α. In terms of probability, π(ai, α) = Pr(Ai = ai). Then, according to the independent
Bernoulli probability assumption for α, π(ai, α) = Πnik=1α
aik(1− α)1−aik .
The various contrasts in survival probabilities for different combinations of treatment
and allocation strategies are possible causal estimands of interest. To properly introduce
these estimands, first the following has to be defined,
F̄ij(t, a, α) =
∑
ai,−j∈A(ni−1)




I{Tij(ai) ≤ t}π(ai, α),








j=1 F̄ij(t, α). F̄i(t, a, α) can be
interpreted as the average probability that an individual will fail by time t in group i when
the individual receives a and the group adopts allocation strategy α. Similarly, F̄i(t, α)
can be interpreted as the average probability that an individual will fail by time t in
group i when the group adopts allocation strategy α . Finally, µ(t, a, α) = E{F̄i(t, a, α)}
is the population average potential cumulative distribution at the point t for treatment
a under allocation strategy α. Similarly µ(t, α) = E{F̄i(t, α)} is the population average
overall potential cumulative distribution at the point t under allocation strategy α. A
possible interpretation of µ(t, a, α) might be as the probability of an individual’s survival
time being less than t under the counterfactual case that an individual receives treatment
a under allocation strategy α,. Again, a possible interpretation of µ(t, α) might be as
the probability of an individual’s survival time being less than t under the counterfactual
case that the group allocation probability of treatment is α.
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The various causal effects of interest are as follows. Comparison of the probability
of event of treated individuals with untreated at a particular allocation level gives rise
to direct effect. The population average direct effect at time t with the data having
allocation probability α is given by DE(t, α) = µ(t, 0, α) − µ(t, 1, α). Subtraction of
the probability of event for two different levels of allocation among the untreated gives
rise to the indirect effect. For allocation strategies α1 and α2, the population average
indirect effect is then given by IE(t, α1, α2) = µ(t, 0, α1) − µ(t, 0, α2). The difference
TE(t, α1, α2) = µ(t, 0, α1)−µ(t, 1, α2) is termed as the total effect. This is the difference
between the probability of event of untreated individual at allocation level α1 and treated
individuals at allocation level α2. The final effect of interest to be discussed is the overall
effect. The calculation of this involves subtracting the probability of event of individuals
at allocation level α1 and individuals at allocation level α2, i.e. OE(t, α1, α2) = µ(t, α1)−
µ(t, α2).
3.2.2 Assumptions
The following assumptions are made:
I) Conditional independence: Ai ⊥ Ti(.)|Li,
II) Positivity: Pr(Ai = ai|Li = l) > 0 for all ai ∈ A(ni) and l such that Pr(Li = l) > 0,
III) Conditional independent censoring: Ci ⊥ {Ti(.),Ai}|Li.
In the absence of interference, assumption I is a standard assumption made for each
individual. When interference is present, this assumption is extended for the group in-
stead of individuals. Under the no interference assumption, assumption (I) is referred
to as no unmeasured confounding. In this case, assumption (I) states that the observed
treatment assignment for a particular group of individuals is conditionally independent
of the counterfactual outcomes of individuals in that group under the possible group
treatment statuses under the condition that there is no other confounders except those
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observed. Assumption II is termed as positivity. Given all possible values of the mea-
sured confounders, the positivity assumption states that given all possible values of the
measured confounders, the probability of a group being assigned a particular vector of
treatment combination is always positive. Assumption III is related to the censoring
distribution. This assumption proposes that the censoring time for an individual is con-
ditionally independent of the counterfactual time to event under and the actual treatment
assignment for the group when all the possible confounders are given.
3.2.3 Proposed Estimator
In the absence of interference and censoring, Hernán and Robins (2006) showed that
standardization can be used to estimate risk ratios. The form of the standardized estimate
of the counterfactual mean E(Y a) in this case is
m(a) =
ˆ











Ê(Y |A = a,Lij)
where Y denotes the indicator that an individual has had an event till a specific time
point of concern and F̂L denotes the empirical joint distribution of the covariates L. In
previous literature, logistic regression has often been used to estimate Ê(Y |A = a,Lij)
(Taubman et al. 2009) and authors had mainly focused on calculating risk ratios or hazard
ratios. However, the parametric g formula might be extended for cases with time to event
data and interference. The proposed estimator for the causal and survival quantities of
interest µ(t, a, α) defined in Section 3.2.1 is as follows-
mint(t, a, α, ω̂) =
ˆ ∑
ai,−k∈A(ni−1)
Pr(Tij ≤ t|L = l, A = a,Ai,−k = ai,−k, ω̂)dFL(l)
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×π(ai,−k, α),
where ω̂ is the estimated value of the parameter for the outcome model Pr(T ≤ t|L =
l, A = a,Ai,−k = ai,−k,ω). The positivity assumption ensures that the probability
Pr(T ≤ t|L = l, A = a,Ai,−k = ai,−k,ω) is well defined. Empirically, the estimator
is given by


















minti (t, a, α, ω̂)
Similarly, the proposed estimator for the causal and survival quantities of interest µ(t, α)
defined in Section 3.2.1 is as follows-
mint(t, α, ω̂) =
ˆ ∑
ai∈A(ni)
Pr(Tij ≤ t|L = l,Ai = ai, ω̂)dFL(l)π(ai, α)
Empirically, the estimate is given by

















minti (t, α, ω̂)
The estimators for Pr(Tij ≤ t|L = l, A = a,Ai,−k = ai,−k,ω) and Pr(Tij ≤ t|L = l,Ai =
ai,ω) can be obtained by fitting parametric models. The estimates of the different effects
can also be obtained from this. The estimates of the direct, indirect, total and overall ef-
fects at a particular time point t are given by D̂E(t, α) = mint(t, 0, α, ω̂)−mint(t, 1, α, ω̂),
ÎE(t, α1, α2) = m
int(t, 0, α1, ω̂) − mint(t, 0, α2, ω̂), T̂E(t, α1, α2) = mint(t, 0, α1, ω̂) −
mint(t, 1, α2, ω̂) and ÔE(t, α1, α2) = mint(t, α1, ω̂)−mint(t, α2, ω̂) respectively.
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Known Survival Probability
When the probabilities Pr(Tij ≤ t|L = l, A = a,Ai,−k = ai,−k,ω) and Pr(Tij ≤ t|L =
l,Ai = ai,ω) are known beforehand, then the only parameters that need to be esti-
mated are µ(t, a, α) and µ(t, α). There are no other nuisance parameters. The following
proposition suggests that the proposed estimators are unbiased when the probabilities
Pr(Tij ≤ t|L = l, A = a,Ai,−k = ai,−k,ω) and/or Pr(Tij ≤ t|L = l,Ai = ai,ω) are
known. The proof is given in Section 3.6
Proposition 2. If the outcome probabilities Pr(Tij ≤ t|L = l, A = a,Ai,−k = ai,−k,ω)
are known, then E{minti (t, a, α, ω̂)} = µ(t, a, α) and if the outcome probabilities Pr(Tij ≤
t|L = l,Ai = ai,ω) are known, then E{minti (t, α, ω̂)} = µ(t, α).
Unknown Survival Probability
For unknown outcome probabilities, the distribution of the outcome can be modeled.
According to Munda et al. (2012) the conditional hazard gORij (t|Lij, Aij,Ai,−j, eORi ) of
Tij(ai) can be assumed to be of the following form according to a parametric frailty
model
gORij (t|Lij, Aij,Ai,−j,ω, eORi ) = gOR0 (ωh, t)eORi
× exp (LTijωc(1:p′1) + φ(Ai,−j)ωc(p′1+1:p′) + Aijωc(p′+1)).
Here gOR0 is the baseline hazard function, ωh is the p′′ dimensional vector of parameters of
the baseline hazard function, eORi is a random component following density fORe (eORi ;ωr),
ωc = (ωc(1:p′1),ωc(p′1+1:p′), ωc(p′+1)) is the vector of coefficients having length p
′ + 1 and
ωr is a parameter of the random effect model. The nuisance parameter vector ω =
(ωc,ωh, ωr) is to be estimated from the model. The function φ is a function of the
treatment assignment vector possibly included in the model. Under assumption III, the

















gOR0 (Xij) exp (L
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j=1 ∆ij denotes the number of uncensored cases, L(q) denotes the q-th




exp (−eORi s)f(eORi , ωr)deORi , s ≥ 0.
The estimation of the parameters of the frailty model can be done by maximizing this
log-likelihood function. This can also be represented in terms of estimating equations.
The maximum likelihood estimate for ω is a solution of the following estimating equations
∑
i
ψORck (Xi,∆i,Li,ω) = 0 for k = 1, ..., p
′ + p′′ + 1
Here ψORck = ψORck (Xi,∆i,Li,ω) = ∂l(Xi,∆i,Li,ω)/∂ωk, ωk being the k-th member of ω.
Once these parameters have been estimated, the quantity Pr(T ≤ t|Li, A = a,Ai,−k =
ai,−k, ω̂) required to calculate the proposed estimator can be obtained by integrating out
the effect of the random component. If we assume that the estimated survival function
corresponding to the model for group i is Sg(gORij (t|Li, Aij,Ai,−j, eORi , ω̂)), then,





ij (t|Li, Aij = a,Ai,−j, eORi , ω̂))fORe (eORi ;ωr)deORi
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The outcome is assumed to follow a parametric frailty model with a random ef-
fect component. Specifically, in the simulation performed and the data analyzed,
times to events are assumed to have a gamma frailty distribution. i.e. eORi follows
gamma distribution with variance ωr. In this case, a closed form of expression for
Pr(Tij ≤ t|Li, A = a,Ai,−k = ai,−k, ω̂) can be obtained by integration. It can be shown
easily by integration that
Pr(Tij ≤ t|Li,A = a,Ai,−k = ai,−k, ω̂)
= 1−
ˆ











ω̂rGOR0 (Li,Ai,−j, a, ω̂, t) + 1
}1/ω̂r
Where,
GOR0 (Li,Ai,−j, a, ω̂, t) = exp (L
T





Hence, in this case,


















minti (t, a, α, ω̂)
Equivalently, it can be shown that






















minti (t, α, , ω̂)
Stacking all the estimating equations together, the following vector of estimating


















, and ψORaα = ψORaα (Oi,ω, θORaα ) = minti (t, a, α,ω) −










θOR0 = {ω0, µ(t, a, α)}, the true value of the parameter θOR. Then, from proposition
2, E(minti (t, a, α,ω0)) = µ(t, a, α) i.e., E
(
ψORaα (Oi,ω0, µ(t, a, α))
)
= 0. This can also be
expressed as
´
ψORaα (o,ω0, µ(t, a, α))dFO(o) = 0. Along with maximum likelihood theory,
this implies the following
´
ψOR(o,θOR0 )dFO(o) = 0.




m(θ̂OR − θOR0 ) converges in distribution to a normal distri-
bution with mean 0 and covariance matrix ΣOR for a fixed t. Hence, for a
fixed time point t, the estimate is consistent and asymptotically normal. The
covariance matrix is equal to U(θOR0 )−1V (θOR0 ){U(θOR0 )−1}T where U(θOR0 ) =
E{−ψ̇OR(Oi,θOR0 )}, V (θOR0 ) = E{ψOR(Oi,θOR0 )ψOR(Oi,θOR0 )T}, and ψ̇OR(Oi,θOR) =
∂ψOR(Oi,θ
OR)/∂(θOR)T . So m(t, a, α, ω̂) is consistent and asymptotically normal. Sim-
ilar techniques can be used to show that m(t, α, ω̂) is also consistent and asymp-
totically normal. The asymptotic variance ΣOR can be consistently estimated by
Σ̂OR = Û(θ̂OR)−1V̂ (θ̂OR){Û(θ̂OR)−1}T where Û(θ̂OR) = m−1
∑m
i=1{−ψ̇OR(Oi, θ̂OR)}
and V̂ (θ̂OR) = m−1
∑m
i=1{ψOR(Oi, θ̂OR)ψOR(Oi, θ̂OR)T}. The sandwich variance esti-
mator Σ̂OR can be computed using the R package geex (Saul and Hudgens 2017) and
can be used to construct Wald type confidence intervals.
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3.3 Simulation
To demonstrate the efficacy of the methods discussed, a simulation study was per-
formed. The data were simulated using the following steps
1. First, baseline covariate L1ij was generated randomly. Random variables Vij were
generated following an exponential distribution with mean 20. The baseline covari-
ates L1ij were then assigned to be min{Vij, 100}/10.
2. Random effects bi for generating the treatment probabilities were randomly gener-
ated following a normal distribution with mean 0 and variance 1.0859.
3. Treatment indicators were simulated following a Bernoulli distribution with prob-
ability pij where pij = expit(0.2727− 0.0387L1ij + bi).
4. Random components b′i for generating the potential times to event were generated
randomly from a gamma distribution with mean 1 and variance 10.
5. Then the time to events Tij(ai) were randomly sampled from an exponential dis-
tribution with mean µij where 1/µij = b′i exp (−3.1aij − 0.2
∑
k 6=j aik + 5.3L1ij).
6. Next, another set of random effects eORi were generated randomly following a
gamma distribution with mean 1 and variance 0.1
7. Finally, the censoring times Cij were sampled randomly from an exponential dis-
tribution with mean λ0 where where λ0 = 0.1 exp (0.01L1ij)eORi .
8. An individual was censored, i.e. ∆ij = 1 if Cij < Tij(Ai).
Data were simulated from 250 groups with each group having 30 individuals using
the steps of the simulation. Hence each of the simulated data set had 7500 individuals
in the sample. The steps of the simulation were performed 10,000 times. To check the
indirect effects, several different values of the treatment allocation probability α were
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used for estimation. Each of the 10,000 simulations generated estimates of the quantities
of interest. These estimates were compared with the true value of the estimates obtained
using counterfactual data generated for a large data set. It can be observed that since the
allocation probabilities are Bernoulli, whichever values of the vector ai,−j yield the same
value of
∑
k 6=j aik, also produce the same value for the quantity π(ai,−j, α). So, according
to the data generation mechanism, the population average potential cumulative survival
distribution at the time point t for treatment a under allocation strategy α can be













I{Tij(a, ai,−j) ≤ t}αk(1− α)ni−k−1
Similarly, the population average marginal potential cumulative survival distribution at













I{Tij(a, ai,−j) ≤ t}αk(1− α)ni−k−1
This representation is possible since the data generation mechanism ensures that the
potential time to events are only dependent on the vector ai,−j through the sum of its
elements. A sandwich variance estimator of the proposed estimators was also obtained
for each of the simulated data. For each value of α, the estimated values of the quantities
of interest are calculated by averaging over all the simulated data set. Asymptotic stan-
dard errors were also calculated by taking the mean of the sandwich variance estimator.
Empirical standard errors were calculated as the standard deviation of the estimates.
95% Wald confidence intervals were constructed and coverage probabilities for each value
of α were calculated by taking the proportion of estimators with values within the con-
fidence interval. Results of the simulation are summarized in Table 3.1, which describes
the results obtained in detail for nine different α values at time point 100 days.
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3.4 Data
3.4.1 Cholera Vaccine Study and Analysis
The methods described in Section 3.2 are applied to a cholera vaccine study in Matlab
from a cholera vaccine trial in Matlab, Bangladesh (Ali et al. 2005). Children of ages 2-15
and women were the participants in the study. The vaccine administered was either B
subunit-killed whole-cell oral cholera vaccine or killed whole-cell-only cholera vaccine and
the placebo administered was E. coli K12 placebo. For analysis, the two versions of the
treatments were assumed to be the same and the study participants were randomized to
receive one of the three treatments with equal probability. An individual was considered
a participant only if he/she received two or more doses of the treatment assigned to
him/her. A participation vector was used to keep track of the participants and non-
participants. The doses of treatment and vaccines were administered during the months
of January to May in the year 1985. Three centers were established for vaccination
purposes and maintained as surveillance centers. The data consisted of a total of 121,982
individuals. Previous studies have managed to establish that interference is present
within the data (Perez-Heydrich et al. 2014). But, the issue of censoring in the data has
not been addressed in any of these studies to date.
The data is right censored because the time to having an event of cholera is not
observed for all the individuals. Censoring could be due to an unobserved event within
the duration of the study, migration from study location or death during the follow up
period.
The data were readied for analysis using the following steps. 7 of the 121,982 observed
individuals appeared to be duplicate values and consequently were removed from the data
giving rise to a data with 121, 975 individuals. As mentioned before, the vaccines were
administered during a five-month window. So, even if the date of entry of individuals in
the study were not exactly the same, they were comparable. So, the same date of entry
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was assigned to all the individuals within a particular group for ease of computation. The
representative start date for a group was assumed to be the most recent date of second
vaccination among all the individuals within that group. In case all of the individuals
failed to receive a second vaccination, the representative start date for a group was then
assumed to be the most recent date of first vaccination among all the individuals within
that group. After assigning start dates to all the individuals, it was observed that 34
individuals could not be assigned any start date. Deleting those 34 data observations
121,941 individuals remained within the data. Among them, the representative start
dates for 60 were after the date of contracting cholera which meant that they had a
negative time to event. So those observations could not be used and were deleted from the
data. Again, from the remaining data, 3617 were lost due to migration and 346 were lost
due to death before the representative start date of their group. The remaining 117,918
individuals constituted the final dataset used for analysis. Placebo was administered to
a total of 69,219 individuals and treatment to 48,699 individuals within the final data.
Only 375 were cases of cholera recorded in the control group and 103 in the treatment
group.
As discussed in Section 3.2.3, for fitting the parametric frailty model to the outcome of
interest, i.e., time to cholera, both the baseline hazard function and the frailty distribution
must be specified. There are several choices for the baseline hazard and frailty model
combination.
Table 3.2 summarizes AIC and BIC values for several baseline hazard function and
frailty distribution combinations. From Table 3.2, it can be observed that both AIC and
BIC are minimum for gompertz baseline hazard with gamma frailty distribution. There-
fore, in order to fit the outcome model to the Matlab cholera data, a parametric frailty
model with baseline hazard distribution gompertz and frailty distribution gamma was
selected. For gompertz baseline hazard, the function gOR0 (ωh, t) equals ωh2exp(ωh1t). The
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covariates included in the outcome model were treatment status, proportion of individ-
uals treated in the group, interaction of treatment status and proportion of individuals
treated within the group, age, distance to river, squared age and squared distance to river.
Also, as shown in Section 3.2.3, both the outcome probability as well as the likelihood
function has a closed form expression in this case. As more than 70% of the individuals
in the data were in groups where the proportion of people treated were in between 0.3
and 0.6, the analysis was restricted for those values of α.
3.4.2 Results
Figure 3.1 shows the estimated cumulative probability distribution obtained using the
parametric g formula compared against the IPCW method over time for three different α
values. Although the parametric g formula and the IPCWmethod do not produce exactly
the same curves, the overall trends of both are quite similar. The jumps in probability
for the IPCW estimators are more pronounced than the parametric g formula estimators
after some time. According to the parametric g formula, the cumulative probability seems
to increase at an exponential rate for both the vaccinated and unvaccinated groups. But
the rate of increase is much larger for the control group compared to the vaccine group.
Therefore, the difference in the cumulative probability of cholera between the control
and vaccine group seems to increase with time. So, it can be deduced that the vaccine
effects get more and more pronounced with time. The direct effect of vaccination becomes
increasingly significant over time. However, changes in the policy α also seem to affect
the cumulative probability of cholera. For a particular time point, it can be observed
from Figure 3.1 that, the cumulative probability of cholera decreases with the increment
of allocation strategy α. This reduction is more prominent in the control group than the
vaccine group. This hints at the presence of an indirect treatment effect which affects
untreated individuals as well. This indirect effect or spillover effect or herd immunity
can be explained through interference.
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Figure 3.2 depicts the direct, indirect, total and overall effects at one year after the
start of the study multiplied by 1000. Among all the effects, only the direct effect has a
decreasing trend with the allocation probability. The rest of the effects show an increasing
trend. The direct effect is greater than 0 for all the policy α in between 0.3 and 0.6. For
example, the estimates of the direct effect of treatment at allocation level α = 0.4 is 2.2
with 95% confidence interval (1.5, 2.9) and the direct effect of treatment at allocation level
α = 0.5 is 1.5 with 95% confidence interval (0.9, 2.1). None of the confidence intervals
contain 0 and the higher value of α gives rise to lesser direct effect. Also, it can be said
that for policy α = 0.4, the expected number of people contracting cholera is 2.2 more
in the unvaccinated group compared to the vaccinated group per 1000 individual. The
indirect, total and overall effects are measures of the spillover effect of the vaccine. From
Figure 3.2 it is apparent that higher allocation probabilities translate to greater spillover
effects. For allocation probabilities less than 0.4, the indirect and overall effects are less
than 0 and they are greater than 0 for allocation probabilities greater than 0.4. As an
example, the estimate of the overall effect corresponding to allocation levels α1 = 0.4 and
α2 = 0.6 is 1.5 with confidence 95% confidence interval (1.0, 2.1). So, 1.5 more individuals
are expected to contract cholera if they belong to a neighborhood with policy α = 0.4
compared to a neighborhood with policy α = 0.6 per 1000 individuals.
The Matlab cholera vaccine data has been analyzed previously and causal effects
were calculated at one year of follow up. (Perez-Heydrich et al. 2014) used an inverse
probability weighted method using group weights instead of individual weights. But they
failed to account for the right censoring present within the data. However, the effect plots
show a somewhat similar trend. As an example, for policy level α = 0.32, estimate of
the direct effect according to Perez-Heydrich et al. was calculated to be 5.3 and the 95%
confidence interval was given to be (2.5, 8.1). The parametric g estimate of the direct
effect at allocation level α = 0.32 as shown in Figure 3.2 is 2.8 having 95% confidence
interval (1.7, 3.9). Even though the confidence interval is much wider for the estimate
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provided by Perez-Heydrich et al., still none of the confidence intervals include 0 and
both the effects are greater than 0 again signifying significant direct effect of the vaccine.
3.5 Discussion
In this section, a new method of calculating causal effect for data with interference
and right censoring has been proposed. The method involves fitting an outcome regres-
sion model and using standardization to get a parametric g formula estimate for various
causal effects. The outcome model fitted was a parametric frailty model and the out-
come probability was calculated by integrating out the random effect. The causal effects
discussed in this section are direct effects, indirect effects, total effects and overall effects.
It was proved that the parametric g formula estimator is consistent and asymptotically
normal. Also, the variance matrix was estimated consistently using a sandwich variance
estimator. 95% confidence intervals were also constructed for the point estimates using
these sandwich variance estimators. A simulation study was performed and results were
compared to the true values of the parameters to observe the finite sample performance
of the methods. Finally, causal effect estimates and 95% confidence intervals were calcu-
lated using the parametric g formula methods for a cholera vaccine study conducted in
Matlab, Bangladesh.
The outcome model in this section is specified to be a parametric frailty model.
However, it might be possible to extend these methods and use a Cox proportional
hazards model with a random component instead. Also, a possible future direction of
research might be to try an extend the methods discussed in this section for general
interference instead of partial interference. For analyzing the real data, the outcome
model was selected based on AIC and BIC. It might be possible to come up with a better
method of model selection. The calculation of parametric g formula involves computing
the sum
∑
ai∈A(ni) Pr(T ≤ t|Li,Ai = ai, ω̂). Summing over all possible values of ai might
be computationally difficult. In that case, a Monte-Carlo approach used by Liu et al.
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(2018) might be used to relieve the computational burden. Another shortcoming of this
method is that the outcome model is sensitive to model misspecification. The estimates
can be misleading if the model is not specified correctly. Therefore, one possible direction
for future work might be to explore doubly robust estimators which might be stable under
model misspecification under some regularity conditions.
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Figure 3.1: Estimated cumulative probability of cholera against time for vaccine and

































































Figure 3.2: Direct effect, indirect effect, total effect and overall effect estimates multiplied
by 1000 for different allocation strategies at time t = 1 year. Indirect effects, total effects
and overall effects are with respect to α2 = 0.4. The shaded region denotes the 95%























































α µ(100, 0, α) Bias ESE ASE EC α µ(100, 1, α) Bias ESE ASE EC
0.1 0.348 -0.000 0.025 0.023 94% 0.1 0.469 -0.000 0.025 0.023 94%
0.2 0.368 -0.000 0.023 0.022 94% 0.2 0.494 -0.000 0.022 0.020 94%
0.3 0.391 -0.000 0.022 0.020 94% 0.3 0.519 -0.000 0.019 0.018 94%
0.4 0.413 -0.000 0.020 0.019 95% 0.4 0.543 0.000 0.017 0.016 95%
0.5 0.437 -0.000 0.019 0.018 95% 0.5 0.566 -0.000 0.016 0.015 95%
0.6 0.461 -0.000 0.018 0.018 95% 0.6 0.589 -0.000 0.015 0.014 95%
0.7 0.486 -0.000 0.019 0.018 95% 0.7 0.611 -0.000 0.015 0.014 95%
0.8 0.510 -0.000 0.019 0.018 94% 0.8 0.631 -0.000 0.016 0.015 94%
0.9 0.535 -0.000 0.021 0.020 94% 0.9 0.651 -0.000 0.017 0.016 94%
Table 3.1: Results from simulation study described in Section 3.3. α denotes the allo-
cation probabilities, µ(100, a, α) is the true value of the survival probabilities at time
point 100 for a = 0, 1; bias is the average of µ(100, a, α)−mint(100, a, α, ω̂), ESE is the
empirical standard error, ASE is the average of the sandwich variance estimators and EC
denotes the empirical coverage of the 95% Wald type confidence intervals.
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Gamma Inverse Gaussian Positive Stable
Exponential 5946.42 (6033.51) 5955.73 (6042.83) 5992.52 (6079.61)
Weibull 5888.98 (5985.76) 5898.34 (5995.12) 5935.18 (6031.96)
Gompertz 5858.04 (5954.82) 5867.50 (5964.28) 5904.57 (6001.35)
Loglogistic 5889.35 (5986.13) 5898.70 (5995.48) 5935.41 (6032.19)
Lognormal 7296.60 (7393.38) 7641.41 (7738.18) 6559.83 (6656.61)
Table 3.2: AIC (BIC) values for different baseline hazard functions corresponding to
gamma, inverse Gaussian and Positive stable frailty distributions.
57
CHAPTER 4: DOUBLY ROBUST ESTIMATION FOR DATA WITH
PARTIAL INTERFERENCE AND RIGHT CENSORING
4.1 Introduction
Interference is present if the treatment status of an individual affects the outcome
of another individual in a data (Cox 1958). Interference can often be observed in data
pertaining to infectious diseases. That is because more often than not, the disease status
of an individual depends not only on the vaccination status of that particular individual
but also on the vaccination status of other individuals (Halloran and Struchiner 1991).
When the data can be partitioned into groups such that the members of a group can
interfere within themselves but there is no interference between members of any two dif-
ferent groups then this is a sub-case of interference termed as partial interference Sobel
(2006). The groups can be based on social, temporal and/or geographical similarities
which are apparent from the data. The effect that one might be concerned with due
to a data having interference is termed as peer effect or spillover effect. Examples of
areas concerned with these effects are criminology (Sampson 2010, Verbitsky-Savitz and
Raudenbush 2012), developmental psychology (Duncan et al. 2005, Foster 2010), econo-
metrics (Sobel 2006, Manski 2013) education (Hong and Raudenbush 2006, Vanderweele
et al. 2013), imaging (Luo et al. 2012), political science (Sinclair et al. 2012, Bowers et al.
2013), social media and network analysis (VanderWeele and An 2013, Toulis and Kao
2013, Eckles et al. 2014, Kramer et al. 2014), sociology (Aronow and Samii 2017), and
spatial analyses (Zigler et al. 2012, Graham et al. 2013).
Various methods of inference has been suggested for randomized experiments under
the partial interference setting (e.g., Rosenbaum 2007, Hudgens and Halloran 2008, Baird
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et al 2014, Eckles et al 2016). However, randomized experiments might not always be
feasible to construct or there might be ethical issues arising in performing a randomized
trial. In that case, for observational data, methods proposed by Tchetgen Tchetgen and
VanderWeele (TV) has been proven to be useful. TV provided consistent estimators for
various causal effects of concern using inverse probability weighting (IPW). But, IPW
methods are known to suffer from some serious drawbacks. When the propensity scores
required to calculate the inverse probability weights become small, the estimator is highly
unstable and difficult to compute numerically. The parametric g formula bypasses this
issue and might be used in place of the IPW estimators. Robins (1986) first suggested
the use of g-computation algorithm. Using outcome regression with g-computation gives
rise to the parametric g formula which is calculated using standardization techniques
(Hernán and Robins 2006).
However, both the IPW method and parametric g formula are based on a strong
assumption. The assumption is that the model used in each case is specified correctly.
Otherwise, the estimators will not be consistent. For the IPW estimator, the treatment
model must be correct and for the parametric g formula, the outcome model must be
specified correctly. The doubly robust estimator tries to address this issue by incorpo-
rating robustness. For these estimators, only one of the treatment and outcome model
must be specified correctly for getting consistent estimators. In that sense, the estimator
is robust under model misspecification.
The rest of this section is organized as follows- Section 4.2 discusses the doubly
robust method in detail and develops large sample properties of the estimator, Section
4.3 provides results for various simulation scenarios implemented, data from a cholera
vaccine study conducted in Matlab, Bangladesh is analyzed in Section 4.4, and finally,




Suppose that the data consists of m groups with group i having ni individuals for
i = 1, . . . ,m. The treatment status indicator Aij equals 1 when individual j in group i
receives treatment and Aij = 0 if said individual receives placebo. Represent the vector
(Ai1, Ai2, ..., Aini) by Ai and the vector (Ai1, Ai2, ..., Aij−1, Aij+1..., Aini) by Ai,−j. The
random variables Ai and Ai,−j can take values ai and ai,−j respectively. The notation
Tij(ai) represents the potential time to event for individual j in group i with treatment
ai. Let Ti(.) = {Tij(ai) : ai ∈ A(ni), j = 1, 2, · · · , ni} denote the set of all potential
event times for individuals in group i. Also assume that because of loss to follow up,
completion of study or other reasons, the time to events might be right censored for some
observations. Then the censoring times for individual j in group i might be denoted by
Cij. Further assume that the indicator of censoring ∆ij = I(Tij(Ai) ≤ Cij) and the
observed time to events Xij = min(Tij(Ai), Cij). Denote Xi = (Xi1, Xi2, · · · , Xini) and
∆i = (∆i1,∆i2, · · · ,∆ini). The set containing all 2ni combinations of treatments in a
group with ni observations, is termed as A(ni) for ni = 1, 2, . . .. Consider the vector of
possible covariates to be Lij for individual j in group i. Assume the group sizes ni to be
random variables included in the vector of baseline covariate Lij. For a particular group
i, the matrix of all possible covariates combining all the covariates of the individuals
in the group i is denoted by Li. The overall observed data can be viewed as m i.i.d
observations of (Li,Ai,Xi,∆i) for i = 1, 2, . . . ,m.
There are various causal effects that are of interest. These causal effects are often
represented as different contrasts of expected potential outcomes. When interference is
absent, a popular causal effect of interest is the average causal effect which is defined as
the difference of the expected potential outcomes for treated and untreated individuals.
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In case of interference, various causal effects can be defined along similar lines by con-
sidering contrasts under various counterfactual outcomes (Hong and Raudenbush 2006,
Sobel 2006, Hudgens and Halloran 2008, Tchetgen and VanderWeele 2012). An additional
term of concern for data with interference is the spillover effect or herd immunity which
is not taken into consideration for data without interference. These gives rise to various
casual effects which are not of concern in absence of interference. To define these addi-
tional causal effects, first, the allocation probability α needs to be introduced. Allocation
probability or policy α is defined as the probability of receiving treatment for an indi-
vidual independent of the others. TV interpreted this term as the independent Bernoulli
probability α for individuals being assigned treatment. So, under ithis counterfactual
scenario, everyone receives treatment independently f others with probability α. Accord-
ing to the Bernoulli probability assignment, the probability of a group treatment vector
can be calculated using independence of treatment assignment. So, denoting by π(ai, α),
the probability that group i has treatment vector ai under allocation policy α, it can be
deduced that π(ai, α) = Prα(Ai = ai) =
∏ni
k=1 α
aik(1 − α)1−aik . Similarly, denoting by
π(ai,−j, α), the probability that group i except for individual j has treatment vector ai,−j,




Here Prα(·) corresponds to the probability under this counterfactual setting.
The causal effects of interest at a particular time point t are defined as contrasts
of population average potential cumulative probability or population average marginal
potential cumulative probability of an event before time t. To define these, first the
average probability of individual j in group i observing an event by time t when said
individual receives treatment a and the allocation strategy of group i is α has to be
defined as follows
F̄ij(t, a, α) =
∑
ai,−j∈A(ni−1)
I{Tij(a, ai,−j) ≤ t}π(ai,−j, α).
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Similarly, the marginal average probability of individual j observing an event in group i
by time t when said individual receives treatment a and the allocation strategy of group




I{Tij(ai) ≤ t}π(ai, α).
Then, let F̄i(t, a, α) = n−1i
∑ni




j=1 F̄ij(t, α). The quan-
tity F̄i(t, a, α) is the representation of the average probability of an individual observing
an event in group i by time t when said individual receives a and the allocation strategy of
group i is α. Similarly, F̄i(t, α) is the representation of the marginal average probability
of an individual observing an event in group i by time t when the allocation strategy of
group i is α. Hence, µ(t, a, α) = E{F̄i(t, a, α)} can be termed as the population average
potential cumulative distribution at time point t for treatment a under allocation strat-
egy α. Similarly, µ(t, α) = E{F̄i(t, α)} can be termed as the population average marginal
potential cumulative distribution at time point t under allocation strategy α. The term
µ(t, a, α) has the interpretation as the probability of an individual’s time to event be-
ing less than t under the counterfactual scenario that an individual receives treatment
a with the group allocation probability being α. For example, in the Matlab cholera
vaccine study described in section 4.4, µ(t, a, α) equals the population average potential
cumulative probability of an individual to get infected with cholera before time t when
the individual receives treatment a and the group treatment allocation probability is α.
Finally, the causal effects of interests can be defined in terms of contrasts of µ(t, a, α)
and µ(t, α). The primary effects of treatment on the outcome is measured through di-
rect effect which is defined as the contrast between the population average potential
cumulative probability for treatment and control for a particular time point and pol-
icy. Mathematically, the direct effect of treatment on the outcome at time point t for
allocation level α can be given by DE(t, α) = µ(t, 0, α) − µ(t, 1, α). The rest of the
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causal effects are concerned with the spillover effect or herd immunity in addition to
the direct effect of treatment. For example, the indirect effect is defined as the contrast
between the population average potential cumulative probability for two different allo-
cation levels under no treatment for a particular time point. This effect measures how
treatment indirectly affects the outcome through herd immunity in the unvaccinated
group and is given by IE(t, α1, α2) = µ(t, 0, α1) − µ(t, 0, α2) for allocation strategies
α1 and α2. The total effect is defined as the contrast between the population aver-
age potential cumulative probability for two different allocation levels under treatment
and no treatment for a particular time point. This effect can be interpreted as an ag-
gregate measure of the direct and indirect effects of treatment. Mathematically, the
total effect of treatment on the outcome at time point t for allocation level α1 and
α2 can be given by TE(t, α1, α2) = µ(t, 0, α1) − µ(t, 1, α2). So, it can be seen that
TE(t, α1, α2) = DE(t, α2) + IE(t, α1, α2). Lastly, the overall effect is used to measure
the overall effect of the allocation strategy irrespective of the treatment status. Defined
as the contrast between the population average marginal potential cumulative proba-
bility for two different allocation levels at a particular time point, the overall effect
can be viewed as a combination of direct and indirect effects. The overall effect can
be written as OE(t, α1, α2) = µ(t, α1) − µ(t, α2). It can be seen that since µ(t, α) =
(1− α)µ(t, 0, α) + αµ(t, 1, α), OE(t, α1, α2) = IE(t, α1)− α1DE(t, α1) + α2DE(t, α2).
4.2.2 Assumptions
Assume the following,
I) Conditional independence: Ai ⊥ Ti(.)|Li,
II) Positivity: Pr(Ai = ai|Li = l) > 0 for all ai ∈ A(ni) and l such that Pr(Li = l) > 0,
III) Conditional independent censoring: Ci ⊥ {Ti(.),Ai}|Li.
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Assumptions I and II are generalizations of individual level assumptions for inter-
ference. Both of these are assumed in case of no interference as well. However, for
no interference the assumptions are made on individuals whereas with interference the
assumptions must be extended for groups instead of individuals. For example, for no
interference, assumption I, commonly referred to as no unmeasured confounding states
that the potential outcome for each individual under each particular treatment is inde-
pendent of the actual treatment assignment of the individual given all of the measured
confounders for the individual. A simple extension states that the potential outcome for
all individuals of a group is independent of the actual treatment assignment of the group
given all of the measured confounders for the group. Similarly, assumption II, termed
as positivity, signifies that each group has a positive probability of being assigned every
possible treatment combination given all of the measured confounders for the group. As-
sumption III pertains to the censoring distributions. It states that for each individual,
given the set of measured confounders for the individual’s group, the potential outcome of
a group and the observed group treatment assignment are jointly conditionally indepen-
dent of the censoring time of for that group given covariates. It can be shown that this
assumption can be relaxed further to make the censoring times depend on the treatment
status.
4.2.3 IPCW and Parametric G Formula Estimators
For interference, the TV IPW estimators with group propensity scores can be ex-
tended with censoring weights to formulate IPCW estimators with group propensity
scores to estimate µ(t, a, α) and µ(t, α) as follows- µ̂(t, a, α) = m−1
∑m
i=1 F̂i(t, a, α) and
µ̂(t, α) = m−1
∑m
i=1 F̂i(t, α) where





π(Ai,−j;α)I(Aij = a)I(∆ij = 1)I(Xij ≤ t)









π(Ai;α)I(∆ij = 1)I(Xij ≤ t)
Pr(Ai|Li, β̂) Pr(∆ij = 1|Li, Xij, γ̂)
.
The estimated parameters β̂ and γ̂ are used to calculate the group propensity scores
Pr(Ai|Li, β̂) and censoring weights Pr(∆ij = 1|Li, Xij, γ̂) respectively. Methods for cal-
culating the propensity score model and censoring model are discussed later. From
these IPCW estimates ,the various causal effects can also be estimated as follows-
D̂E(t, α) = µ̂(t, 0, α)− µ̂(t, 1, α), ÎE(t, α1, α2) = µ̂(t, 0, α1)− µ̂(t, 0, α2), T̂E(t, α1, α2) =
µ̂(t, 0, α1) − µ̂(t, 1, α2) and ÔE(t, α1, α2) = µ̂(t, α1) − µ̂(t, α2). Under the assumptions
discussed before and when the treatment and censoring models are correctly specified,
the IPCW estimator can be shown to be consistent and asymptotically normal.
The group propensity scores Pr(Ai|Li, β̂) required to calculate the IPCW estimators
might become too small for large groups and numerical calculation might become unfea-
sible. One way to circumvent this problem might be to use parametric g formula to find
estimators for µ(t, a, α) and µ(t, α). The parametric g formula estimator for µ(t, a, α), in
this case, can be given by
mint(t, a, α, ω̂) =
ˆ ∑
ai,−k∈A(ni−1)
Pr(T ≤ t|L = l, A = a,Ai,−k = ai,−k, ω̂)dFL(l)
× π(ai,−k, α).
The outcome probability Pr(T ≤ t|L = l, A = a,Ai,−k = ai,−k, ω̂) can be estimated by
fitting a parametric model which is discussed in detail in the following sections. Here ω̂
is an estimator of the parameter for the outcome model. The quantity Pr(T ≤ t|L =
l, A = a,Ai,−k = ai,−k,ω) is well defined because of assumption II. The integral in
the estimator can be replaced by sum and the parametric g formula estimator can be
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empirically calculated based on the empirical distribution of L as-






























minti (t, a, α, ω̂)
where mij(a, ai,−j, t,Li, ω̂) = Pr(T ≤ t|Li, A = a,Ai,−k = ai,−k, ω̂). Similarly, the
parametric g formula estimator for µ(t, α) is given as-
mint(t, α, ω̂) =
ˆ ∑
ai∈A(ni)
Pr(T ≤ t|L = l,Ai = ai, ω̂)dFL(l)π(ai, α)
and empirically the estimator is calculated as-





























minti (t, α, ω̂)
where mij(ai, t,Li, ω̂) = Pr(T ≤ t|Li,Ai = ai, ω̂). Based on these parametric g estima-
tors, the causal effect estimates are given by D̂E(t, α) = mint(t, 0, α, ω̂)−mint(t, 1, α, ω̂),
ÎE(t, α1, α2) = m
int(t, 0, α1, ω̂) − mint(t, 0, α2, ω̂), T̂E(t, α1, α2) = mint(t, 0, α1, ω̂) −
mint(t, 1, α2, ω̂) and ÔE(t, α1, α2) = mint(t, α1, ω̂) − mint(t, α2, ω̂). Under the assump-
tions discussed before and when the outcome model is correctly specified, the parametric
g formula estimator can be shown to be consistent and asymptotically normal.
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4.2.4 Proposed Estimator
An important intrinsic assumption for both the IPCW estimator and the parametric
g formula is that the underlying models are specified correctly. If this does not hold
true then the consistency and asymptotic normality of the estimators are not valid. The
doubly robust estimator provides an alternative to these methods where the estimator is
supposedly robust under some model misspecifications. Liu et al. (2018) extended doubly
robust estimators to the case of partial interference. The estimators put forth by them
has the following form-














where Yij is the potential outcome of interest and mij(ai,Li,ω) = E(Yij|ai,Li,ω). Ex-
tending Liu et al.’s estimate for data with right censoring, considering Yij = I(Xij ≤ t)











ij = 1){I(Xij ≤ t)−mij(Ai, t,Li, ω̂)}π(Ai,−j;α)




mij(a, ai,−j, t,Li, ω̂)π(ai,−j;α)
]
.
Along the same lines, the doubly robust estimator for µ(t, α) adjusting for censoring is
given by-







I(∆tij = 1){I(Xij ≤ t)−mij(Ai, t,Li, ω̂)}π(Ai;α)








where ∆tij = 1 if T tij(Ai) ≤ Cij and ∆tij = 0 otherwise and T tij(.) = min(Tij(.), t).
Using the time dependent censoring indicator ∆tij instead of the original censoring indi-
cator ∆ij yields a more efficient estimator in this case because individuals censored after
time t will contribute the information in the estimator. And as before, the estimates
for the causal effects can be given as follows- D̂E(t, α) = F̂DR(t, 0, α) − F̂DR(t, 1, α),
ÎE(t, α1, α2) = F̂
DR(t, 0, α1)−F̂DR(t, 0, α2), T̂E(t, α1, α2) = F̂DR(t, 0, α1)−F̂DR(t, 1, α2)
and ÔE(t, α1, α2) = F̂DR(t, α1)− F̂DR(t, α2).
4.2.5 Properties of the Proposed Estimator
The definition of the doubly robust estimator entails the estimation of three sets of
nuisance parameter β, γ, and ω. For observational data, these parameters are not known
beforehand and must be estimated from the observed data to calculate the value of the
estimate.
Following the parametric frailty models formulated by Munda et al. (2012), the cen-
soring times cij were assumed to follow a parametric frailty model. The conditional
hazard for the censoring times is given by gij(c|Lij, ei) = g0(c;θh)ei exp (LTijθc). Here,
the baseline hazard function is denoted by g0, θh is the q′- dimensional vector of param-
eters for the baseline hazard function, the random effect ei is assumed to follow density
fe(ei; θr), and the vector of parameters corresponding to the covariates are denoted by
θc, which is is q-dimensional. So, the overall vector of parameters for the parametric
frailty model γ is given as γ = (θc,θh, θr). The vector of parameters γ is estimated
using maximum likelihood estimators. Hence, following assumption III, the contribution























i2, · · · ,∆tini),
dti =
∑ni




g0(κ)dκ, and L(s) is the s-th derivative of the Laplace transform of the
frailty distribution, i.e., L(s) =
´∞
0
exp (−eis)fe(ei; θr)dei. In terms of estimating equa-




ψck(Xi,∆i,Li,γ) = 0 for k = 1, ..., q + q′ + 1,
where ψck = ψck(Xi,∆i,Li,γ) = ∂l(Xti,∆ti,Li,γ)/∂γk and γk is the k-th element of γ.
The calculation of censoring weight can be simplified by the choice of baseline hazard
and frailty distribution. Specifically, in this section, a constant value equal to θh is
used as the baseline hazard for the censoring model.Then the conditional hazard is given
as gij(c|Lij, ei) = θh exp (Lijθc)ei. Also, it is assumed that the frailty term ei follows
a gamma distribution with mean 1 and variance θr. Under these specifications, the
censoring weights can be obtained exactly using the closed form obtained below-



















θrθhX tij exp (Lijθc) + 1
}1/θr
Next, the group propensity weights must be estimated. TV (2012), used a mixed
effects model for the treatment indicator, i.e., Pr(Aij = 1|Lij, bi) = logit−1(Lijθx + bi) to
estimate the group propensity scores. Here, θx corresponds to the covariate parameters
and bi is a random effect following density fb(bi; θs). Then, the vector of parameters for
the mixed effects model is give by β = (θx, θs). Maximum likelihood theory is again
employed for the estimation of the parameter vector β. The contribution of group i to
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where hij(bi,Li,β) = Pr(Aij = 1|Lij, bi). The likelihood for group i is obtained by inte-
grating over the random effect for group i. Similarly as before, the maximum likelihood
estimator of β can be formulated as the solution to the vector of estimating equations
∑
i
ψxk(Ai,Li,β) = 0 for k = 1, ..., p+ 1,
where ψxk = ψxk(Ai,Li,β) = ∂l(Ai,Li,β)/∂βk, βk is the k-th element of β.
Finally, the time to events must be modeled. According to Munda et al. (2012), again
a parametric frailty model can be employed for this purpose. For the outcome model,
the conditional hazard gORij (t|Lij, Aij,Ai,−j, eORi ) for Tij(ai) is given by
gORij (t|Lij, Aij,Ai,−j,ω, eORi ) = gOR0 (ωh, t)eORi
× exp (LTijωc(1:p′1) + φ(Ai,−j)ωc(p′1+1:p′) + Aijωc(p′+1)).
Again, as before, gOR0 denotes the baseline hazard function, the p′′ dimensional parameter
vector corresponding to the baseline hazard function is given by ωh, eORi is the frailty term
following density fORe (eORi ;ωr), ωc = (ωc(1:p′1),ωc(p′1+1:p′), ωc(p′+1)) is a p
′ + 1 dimensional
vector of coefficients corresponding to the covariates and ωr is a parameter of the random
effect model. The overall vector of parameters corresponding to the outcome model is
then ω = (ωc,ωh, ωr). This vector of nuisance parameter is not known beforehand and
must be estimated from the data. The treatment assignment vector is incorporated in
the model through the function φ. For example, in this section, φ is assumed to be the
proportion of treated individuals in each group. As before, the contribution of group

















gOR0 (Xij) exp (L
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j=1 ∆ij denotes the number of uncensored cases, L(q) denotes the q-th




exp (−eORi s)f(eORi , ωr)deORi , s ≥ 0.
The parameters are estimated using maximum likelihood. For obtaining these, the cor-
responding score equations must be maximized. Hence, these score equations can be
represented as a set of estimating equations and the maximum likelihood estimate for ω
can be interpreted as the solution of the following estimating equations
∑
i
ψORck (Xi,∆i,Li,ω) = 0 for k = 1, ..., p
′ + p′′ + 1,
where ψORck = ψORck (Xi,∆i,Li,ω) = ∂l(Xi,∆i,Li,ω)/∂ωk, ωk being the k-th member of
ω. For calculating the estimators proposed in Section 4.2.4, quantity Pr(T ≤ t|Li, A =
a,Ai,−k = ai,−k, ω̂) must be calculated. Using the estimated values of ω̂, the term can
be calculated easily and the proposed estimator can be obtained by integrating out the
effect of the random component. If the estimated survival function corresponding to the
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model for group i is given by Sg(gORij (t|Li, Aij,Ai,−j, eORi , ω̂)), then,





ij (t|Li, Aij = a,Ai,−j, eORi , ω̂))fORe (eORi ;ωr)deORi
So, to estimate the probability Pr(T ≤ t|Li, A = a,Ai,−k = ai,−k, ω̂), a parametric
frailty model is assumed for the time to events and the conditional survival probabilities
must be integrated with respect to the random component. In all the analysis performed
in this section, the parametric frailty model employed is assumed to have a frailty distri-
bution. of gamma. Specifically, eORi follows gamma distribution with variance ωr. For a
gamma frailty, the quantity Pr(T ≤ t|Li, A = a,Ai,−k = ai,−k, ω̂) can be obtained as a
closed form by computing the exact integral mathematically. Using integral calculus we
can show the following-
Pr(T ≤ t|Li,A = a,Ai,−k = ai,−k, ω̂)
= 1−
ˆ











ω̂rGOR0 (Li,Ai,−j, a, ω̂, t) + 1
}1/ω̂r
Here,
GOR0 (Li,Ai,−j, a, ω̂, t) = exp (L
T






So, it follows that


















minti (t, a, α, ω̂).
Similarly,





















minti (t, α, , ω̂)
Therefore, considering the estimation of all the aforementioned parameters as well as
the parameters of interest for obtaining the causal effects, the overall vector of estimating












)T , ψc =
(ψc1, ψc2, ..., ψcq+q′+1)
T , ψx = (ψx1, ψx2, ..., ψxp)









and ψDRaα = ψDRaα (Oi,θDR) = F̂DR(t, a, α) − θDRaα . The vector of parameters to be es-
timated from the estimating equations is θDR =
(





vector of solutions are obtained using maximum likelihood theory and using the proposed
estimators and is given by θ̂ = (θ̂c, θ̂h, θ̂r, θ̂x, θ̂s, ω̂, θ̂DRaα ). Finally, the true value of the
parameters are denoted by of β, γ, and ω by β0, γ0, and ω0.
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Proposition 3. If either (i) the propensity model and the censoring model are cor-
rectly specified or (ii) the outcome model is correctly specified then
√
m{F̂DR(t, a, α) −
µ(t, a, α)} converges to a normal distribution with mean 0 and variance ΣDR as
m → ∞ where ΣDR = τU(θDR)−1V (θDR){U(θDR)−1}T τT where U(θDR) =
E{−ψ̇DR(Oi,θDR)}, V (θDR) = E{ψDR(Oi,θDR)ψDR(Oi,θDR)T}, ψ̇DR(Oi,θDR) =
∂ψDR(Oi,θ
DR)/∂(θDR)T , and τ = (0, 0, . . . , 0, 1).
The proof of Proposition 3 is given in Section 4.6. The asymptotic variance ΣDR can
be consistently estimated by Σ̂DR = Û(θ̂DR)−1V̂ (θ̂DR){Û(θ̂DR)−1}T where Û(θ̂DR) =
m−1
∑m
i=1{−ψ̇DR(Oi, θ̂DR)} and V̂ (θ̂DR) = m−1
∑m
i=1{ψDR(Oi, θ̂DR)ψDR(Oi, θ̂DR)T}.
The sandwich variance estimator Σ̂DR can be computed using the R package geex (Saul
and Hudgens 2017) and can be used to construct Wald type confidence intervals.
4.3 Simulation
To demonstrate the efficacy of the methods discussed, a simulation study was per-
formed. The data was simulated using the following steps
1. First, baseline covariates L1ij, L2ij, L3ij, and L4ij was generated randomly as fol-
lows. L1ij was generated following a standard normal distribution, L2ij was gener-
ated following a Bernoulli distribution with probability of success 0.5, and L3ij was
generated following a chi-square distribution with 1 degree of freedom. To gener-
ate L4ij, first, random variables Vij were generated following an inverse Gaussian
distribution with mean 1. The baseline covariates L4ij were then assigned to be
V 2ij + L3ij.
2. Random effects bi for generating the treatment probabilities were randomly gener-
ated following a normal distribution with mean 0 and variance 1.
3. Treatment indicators were simulated following a Bernoulli distribution with proba-
bility pij where pij = expit(1−β|L1ij|+ bi). The value of β is varied from 0.1 to 1.0
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with an increment of 0.1 to get 10 sets of simulated data. The different simulation
settings are denoted by alphabets a through j respectively.
4. Random components eORi for generating the potential times to event were generated
randomly from a gamma distribution with mean 1 and variance 0.1.
5. Then the time to events Tij(ai) were randomly sampled from
an exponential distribution with mean µij where 1/µij =
0.6eORi exp (−7.4aij − 12.7
∑
k 6=j aik/ni + 10|L1ij| − 7.4L2ij + 20L1ijL2ij).
6. Next, another set of random effects ei were generated randomly following a gamma
distribution with mean 1 and variance 10
7. Finally, the censoring times Cij were sampled randomly from an exponential distri-
bution with mean λ0 where where 1/λ0 = 0.01ei exp (2|L1ij| − 10L2ij + 5L1ijL2ij).
8. An individual was censored, i.e. ∆ij = 1 if Cij < Tij(Ai).
9. The misspecified outcome model was obtained by fitting a parametric frailty model
to the time to events with the covariates treatment,
∑
k 6=j aik/ni, |L1ij|, and L2ij.
10. The misspecified treatment model was obtained by fitting a logistic mixed effects
model to the treatment indicators with covariates L4ij.
11. Finally, the misspecified censoring model was obtained by fitting a parametric
frailty model to the censoring times with covariate L1ij.
The steps from 1 to 8 were performed iteratively a large number of times. For each of the
simulated data, the number of groups was fixed to be 200 and the number of individuals
in each group was fixed to be 30. So, for every set of simulation, the total number of
individuals was 6000. The true values of the parameters of interest were obtained from
the simulated data by using the complete simulated data on the counterfactuals for a
large data set. The allocation probabilities used ranged from 0.1 to 0.9 with an increment
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of 0.1. So, the total number of allocation probabilities explored was 9. The estimates of
the parameters of interest were also obtained for each of the simulated data set. These
estimates were compared with the true value of the estimates. Note that the Bernoulli
allocation probabilities, in this case, have the following property: if
∑
k 6=j aik is the same
for two different values of the vector ai,−j, then π(ai,−j, α) will also be the same for those
two treatment vectors. Hence, in this case, the population average potential cumulative
survival distribution at the time point t for treatment a under allocation strategy α can













I{Tij(a, ai,−j) ≤ t}αk(1− α)ni−k−1
An equivalent explanation yields that the population average marginal potential cu-














I{Tij(a, ai,−j) ≤ t}αk(1− α)ni−k−1
This is a special case of partial interference and this representation is possible because
of the fact that the contribution of the vector ai,−j towards the time to events is only
through the sum of its elements
∑
k 6=j aik. The estimated asymptotic standard errors were
also obtained using the sandwich variance estimator discussed in the previous section for
each of the simulated data for each α. The representative value of the estimate and
the asymptotic standard error were calculated as the average over all the simulated data
set. Standard errors were also calculated empirically from the estimates obtained from
each of the simulated data set. The asymptotic standard errors were used to construct
95% Wald confidence intervals. Finally, for each value of α, coverage percentages were
calculated by observing the percentage of estimated values lying within the confidence
interval over all the simulated data set.
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Fitting all the correctly specified models, 1000 iterations of simulation setting e were
performed. The results are summarized in Table 4.1, which describes the results obtained
in detail for nine different α values at time point 100 days. From the table, it can be
observed that the bias is close to 0 in general. Also, the Wald type 95% confidence
intervals seem to attain the nominal level.
Figure 4.1 and Figure 4.2 show the absolute biases of the estimates F̂DR(t, a, α) for the
different simulation settings a through j for untreated and treated individuals respectively
for α = 0.5. Similarly, Figure 4.3 and Figure 4.4 show the coverages of the 95% Wald
type confidence intervals for the different simulation settings a through j for untreated
and treated individuals respectively for α = 0.5. These plots contain results for IPCW,
parametric g as well as doubly robust estimators under four different scenarios. These
are, i) when the outcome model, treatment model, and censoring model are all specified
correctly, ii) when the outcome model is specified incorrectly but the treatment and cen-
soring models were specified correctly, iii) when only the outcome model was specified
correctly but both the treatment and censoring model were specified correctly, and iv)
when all the three models are specified incorrectly. The IPCW estimators were particu-
larly sensitive towards the actual distribution of the propensity scores. Depending on how
the propensity scores were distributed, the IPCW estimators were either always unbiased
or always biased irrespective of the models being correctly or incorrectly specified. Simu-
lation scenarios a through j were used to compare the estimators for different propensity
distributions. From the figures, note that the bias of the IPCW method for incorrectly
specified treatment and censoring models is quite close to 0 for simulation setting a and
increases from simulation setting b through j. However, if only one set of models are in-
correctly specified, then, across all the simulations, the doubly robust estimator performs
uniformly better in terms of bias as well as coverage than the corresponding estimator for
which the model(s) has(have) been misspecified thus demonstrating the doubly robust
property of the estimator.
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4.4 Data Analysis
4.4.1 Cholera Vaccine Study and Analysis
In order to show the performance of the methods described in Section 4.2, data from
a cholera vaccine study in Matlab, Bangladesh (Ali et al. 2005) are analyzed. The study
participants consisted of children of ages 2-15 and women. There were two versions of
vaccine administered. They were B subunit-killed whole-cell oral cholera vaccine or killed
whole-cell-only cholera vaccine. The placebo used on the participants for this study was
E. coli K12 placebo. However, according to SUTVA, it is assumed that there is only one
version of treatment and control. Hence, the two treatments are considered to be the
same treatment. Individuals in the study randomly received one of the three treatments.
Participation in the study was based on whether an individual received two or more
doses of the treatment or vaccine assigned to him/her. Since non participants were also
included in the analysis of the study, a matrix with information on whether an individual
participated in the study or not was maintained. The assignment of treatment or control
to an individual in the Matlab study was irrespective of their participation status. The
dates of vaccination ranged from January to May 1985. Three centers for vaccination
were established in the Matlab area and later, these were used as surveillance centers
for end point data collection. The total number of individuals in the data consisted was
121,982. The presence of interference has been established by a number of studies of the
data in the past (Perez-Heydrich et al. 2014). However, in all of those studies, the issue
of right censoring was ignored.
Not all the individuals in the study observe an event of cholera. For those who do
not, the time to incidence of cholera is censored. Hence, the presence of right censoring
is evident in the data. There are a number of causes of censoring like migration from
study location or death during the follow up period.
Before proceeding with the analysis, the data was prepared accordingly as follows.
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7 duplicate values were observed in the 121,982 observed individuals. These observa-
tions were removed from the data and there remained a total of 121, 975 individuals.
Note that, the date of vaccination was not the same for all individuals as previously
mentioned. However, since the range of vaccination was only five months, the date of
vaccination of individuals were quite close to each other. Therefore, for convenience of
analysis, individuals within the same group were assigned the same date of entry into the
study. The entry date for an individual was defined to be the most recent date of second
vaccination among all the individuals within the group to which that particular individ-
ual belonged. There were some groups in which none of the individuals received a second
vaccination. For those groups, the start date was defined as the most recent date of first
vaccination among all the individuals within that group. During the process of assigning
start dates to individuals, it was observed that 34 individuals could not be assigned any
start date as nobody in their group were given a single dose of either vaccine or placebo.
These observations were also removed giving rise to 121,941 individuals. After that, it
was again observed that 60 of the observations had start dates assigned to them which
were before the date of them contracting cholera. Since time to contract cholera cannot
be negative, those observations were deleted. Along similar lines, the dates of migration
of 3617 individuals and the dates of death for 346 individuals were were observed to be
before their group’s start date and hence they had to be removed as well and 117,918 in-
dividuals remained. This is the dimension of the final data that was ultimately analyzed.
Within this, there were 69,219 individuals who received placebo and there were 48,699
individuals who received treatment. The number of cases of cholera was very small, i.e.,
in the control and treatment group, there were 375 and 103 cases of cholera reported
respectively.
While calculating the propensity score for the estimator, the largest 15 groups posed a
problem as their group propensity scores were very close to 0. Because of this, the weights
were abnormally large and numerical calculations could not be performed using those
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weights. So, these groups had to be be omitted as well. The probability of vaccination
was 2/3 in the data if the two groups of vaccines were merged together. The probability
of participation was modeled using a mixed effects model following Perez-Heydrich et.
al.. Age, squared age, distance to nearest river, and squared distance to nearest river were







where hij(bi,Li,θx)} = Pr(Bij = 1|bi,Lij,θx)) = expit(Lijθx + bi), and (θ̂x, θ̂s) is the
maximum likelihood estimate of (θx, θs). For the censoring model, checking individually
for statistically significant predictors of censoring, age was chosen as the most significant
predictor. Specifically, the censoring times were modeled using a parametric frailty model
as exponential random variables with mean θhci exp (ageijθc), where ci was assumed to
follow a gamma distribution with mean 1 and variance θr.
Following Section 4.2, a parametric frailty model is fitted to the outcome of interest,
i.e., time to Cholera. For completely specifying the outcome model, there must be a
baseline hazard function and a frailty distribution given. Many different combinations of
choices were considered for this model.
The AIC and BIC values for several baseline hazard function and frailty distribution
combinations are provided in Table 4.2. Both the AIC and BIC values seem to reach their
minimum value corresponding to baseline hazard distribution gompertz and frailty distri-
bution gamma. So, the times to incidence of cholera were assumed to follow a parametric
frailty model with baseline hazard distribution gompertz and frailty distribution gamma.
For gompertz baseline hazard, the function gOR0 (ωh, t) equals ωh2exp(ωh1t). Treatment
status, proportion of individuals treated in the group, interaction of treatment status
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and proportion of individuals treated within the group, age, distance to river, squared
age and squared distance to river were all used as explanatory variables in the outcome
model. Note that, from Section 4.2.5, we can obtain a closed form expression for both
the outcome probability as well as the likelihood function since the frailty is gamma. The
allocation probabilities that were used for analysis ranged from 0.3 and 0.6 because over
70% of individuals had values of α within that range.
4.4.2 Results
The direct, indirect, total and overall effects at one year per thousand persons ob-
tained from the cholera vaccine study are summarized in Figure 4.5. From the figure, it
can be observed that the direct effect is a function of the policy α. The direct effect seems
to be inversely related to the allocation probability. Also, the 95% confidence interval for
the direct effect includes 0 only for α greater than 0.55. So, for α less than or equal to
0.55, there exists a statistically significant direct effect of vaccine on cholera. To illustrate
this, it can be seen that the direct effects and 95% confidence intervals corresponding to
α = 0.45 and α = 0.6 are 4.3 (1.8, 6.9) and 1.6 (−0.4, 3.7) respectively. So, it can be said
that in a population of 1000 individuals, 7.8 more individuals are expected to be infected
with cholera if they are not vaccinated compared to if they are vaccinated. Unlike the
direct effect, all three of the indirect, total and overall effects seem to increase with pol-
icy α. All of these three effects provide different measures of the spillover effect and the
trend suggests a positive spillover effect of the vaccination on the incidence of cholera.
for example, the estimate of the overall effect corresponding to α1 = 0.55 and α2 = 0.4
turns out to be 2.7 with a 95% confidence interval of (1.3, 4.1). This means that almost
3 more individuals are expected to be infected with cholera in a region with allocation
probability 0.4 compared to a region with allocation probability 0.55 irrespective of their
individual treatment status.
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Perez-Heydrich et al. (2014) provided IPW estimates for the direct, indirect, total
and overall effects using group propensity scores instead of individual propensity scores.
The estimates from the doubly robust estimate compare well with the previous results.
The plots of the effects look to be quite similar and the trend is similar as well. For
example, the direct effect (and 95% CI) provided by Perez-Heydrich et. al. is given by
4.03 (2.48, 8.12). Whereas the doubly robust method suggested in this section produces
a point estimate (and 95% CI) of 7.13 (4.06, 10.20). However, the estimators provided
by Perez-Heydrich et. al. suffered from two serious drawbacks that have been addressed
in the methods of this section. The first drawback is that for the IPW estimator, the
propensity model must be correctly specified. But for the doubly robust method, even
if the propensity model and the censoring models are both specified incorrectly, the
estimator might be consistent if the outcome model can be specified correctly. Also, the
IPW estimators do not adjust for censoring.
4.5 Discussion
In this chapter, the doubly robust estimator proposed by Liu et al. (2018) was ex-
tended for data with right censoring. A censoring weight was incorporated in the esti-
mator proposed by them to calculate the new estimator. Using M-estimation theory, the
estimator was shown to be consistent and asymptotically normal when either the treat-
ment model and censoring model are correctly specified or only the outcome model is
correctly specified, validating its doubly robust property. A sandwich variance estimator
was used to construct 95% confidence interval for the estimates. Results from simulation
studies showed that the estimator performed well for finite samples, i.e. the estimator
was robust under model misspecification, it had a low bias, and the coverage was close
to the nominal level of 95%.
The methods were implemented on the cholera vaccine trial and various causal effects
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were estimated. Results were compared with previous studies (Ali et al. 2005, Perez-
Heydrich et al. 2014). In agreement with these studies, it was observed that there was
an inverse relationship of incidence of cholera with the allocation probability. The effects
were obtained as a function of both time and policy. However, none of the previous
studies adjusted for censoring hence being susceptible to selection bias. (Perez-Heydrich
et al. 2014) used an IPW estimator which is sensitive to model misspecification. Results
corresponding to time point one year were discussed in detail in this chapter.
The doubly robust estimator suffers from some of the drawbacks of both the IPCW
and the parametric g formula. For example, large groups might yield a very small value
of group propensity score resulting in an unstable estimator. One way around this issue
can be to use standardized estimator instead of the original one proposed in this chapter.
The parametric g formula estimate might prove to be mathematically cumbersome to
compute as it involves summing over all possible ai. Liu et al. (2018) used a Monte-
Carlo approach to carry out calculations which might be employed n this case as well. A
future direction of work might be to adopt a semi parametric Cox proportional hazard
model instead of the parametric frailty model for the censoring as well as the outcome
model. Naimi and Kennedy (2017) showed that doubly robust methods perform well
when used in conjunction with non-parametric models. This is another avenue worth
exploring in the future. Finally, the methods discussed here might be extended from
partial interference to general interference.
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Figure 4.1: Absolute biases of the doubly robust, parametric g and the IPCW estimators
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Figure 4.2: Absolute biases of the doubly robust, parametric g and the IPCW estimators
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Figure 4.3: Coverages of the doubly robust, parametric g and the IPCW estimators under
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Figure 4.4: Coverages of the doubly robust, parametric g and the IPCW estimators under
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Figure 4.5: Direct effect, indirect effect, total effect and overall effect estimates multiplied
by 1000 for different allocation strategies at time t = 1 year. Indirect effects, total effects
and overall effects are with respect to α2 = 0.4. The shaded region denotes the 95%





















































α µ(100, 0, α) Bias ESE ASE EC α µ(100, 1, α) Bias ESE ASE EC
0.1 0.10 0.02 0.36 0.03 95% 0.1 0.43 0.00 0.13 0.02 97%
0.2 0.14 0.02 0.36 0.04 97% 0.2 0.48 0.00 0.18 0.03 95%
0.3 0.20 0.01 0.13 0.03 96% 0.3 0.53 0.00 0.09 0.03 95%
0.4 0.25 -0.01 0.03 0.02 94% 0.4 0.57 0.00 0.03 0.02 95%
0.5 0.31 -0.01 0.01 0.01 93% 0.5 0.61 0.00 0.01 0.01 95%
0.6 0.37 0.00 0.01 0.01 94% 0.6 0.65 0.00 0.01 0.01 94%
0.7 0.43 0.00 0.01 0.01 95% 0.7 0.68 0.00 0.01 0.01 94%
0.8 0.48 0.00 0.01 0.01 95% 0.8 0.71 0.00 0.01 0.01 95%
0.9 0.53 0.00 0.05 0.03 96% 0.9 0.74 0.00 0.03 0.01 96%
Table 4.1: Results from simulation study described in Section 4.3. α denotes the allo-
cation probabilities, µ(100, a, α) is the true value of the target parameter for a = 0, 1;
Bias is the average of µ(100, a, α) − F̂DR(100, a, α) for a = 0, 1; ESE is the empirical
standard error, ASE is the average of the sandwich variance estimates and EC denotes
the empirical coverage of the 95% Wald confidence intervals.
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Gamma Inverse Gaussian Positive Stable
Exponential 5946.42 (6033.51) 5955.73 (6042.83) 5992.52 (6079.61)
Weibull 5888.98 (5985.76) 5898.34 (5995.12) 5935.18 (6031.96)
Gompertz 5858.04 (5954.82) 5867.50 (5964.28) 5904.57 (6001.35)
Loglogistic 5889.35 (5986.13) 5898.70 (5995.48) 5935.41 (6032.19)
Lognormal 7296.60 (7393.38) 7641.41 (7738.18) 6559.83 (6656.61)
Table 4.2: AIC (BIC) values for different baseline hazard functions corresponding to
gamma, inverse Gaussian and positive stable frailty distributions.
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CHAPTER 5: CONCLUSION
In the field of public health, interest often lies in estimating the effect of a treatment
on an outcome of interest. In the causal inference framework, under the stable unit
treatment value assumption (SUTVA), the causal effect of a treatment on the outcome
can be used as a metric for the effect of treatment. One of the assumptions in SUTVA
states that there is no interference. Interference is said to be present when the outcome
of one individual is affected by the treatment status of another individual. A special case
of interference is partial interference where it is assumed that interference can occur only
between individuals within particular pre-specified groups but not between individuals
of separate groups. In this document, we propose three different methods for estimating
various effects of treatment on outcomes of interest in the presence of partial interference
and right censoring. The different effects include direct effect of treatment as well as
spillover effects due to partial interference.
Tchetgen and VanderWeele (2012) (TV) proposed IPW estimators for causal effects
in the presence of partial interference. But they did not consider the nuances of censoring
in their paper. We considered an extension of the TV IPW estimators by introducing
a censoring weight along with the group propensity weights, previously used by TV.
Following TV, the group propensity scores were obtained by assuming a mixed effects
model for the treatment. The censoring weights were obtained by fitting a parametric
frailty model to censoring times. Using the M-estimation theory, we proved that the
estimator is consistent and asymptotically Normal. We performed simulation studies to
show that the estimator had a very small bias for finite samples. Also, the sandwich
variance estimator of the asymptotic standard error achieved the expected level of 95%
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coverage.
The second method proposed for estimating causal effects was parametric g formula.
The times to events were assumed to follow a parametric frailty model. Standardization
was used to calculate the marginal survival probabilities. Consistency and asymptotic
Normality of the estimator was proved as before using M-estimation theory. Again, sim-
ulation studies showed that the bias of the estimator was small and a sandwich variance
estimator of the asymptotic standard error achieved nominal coverage.
Finally, we combined the IPW and parametric g formula estimators to propose a dou-
bly robust estimator. The doubly robust estimator in the presence of partial interference
and right censoring was obtained by extending the doubly robust estimator proposed
by Liu et al. (2018) in the presence of partial interference only. We showed that the
estimator was robust under model misspecification, i.e., the estimator was consistent and
asymptotically Normal even if only one of the two sets of models were specified correctly,
the outcome model or the censoring and treatment models. Simulation studies were again
useful in showing the finite sample efficacy of the method as before.
All of the three methods discussed in the document were applied to a cholera vaccine
study performed in Matlab, Bangladesh. Different methods yielded slightly different
results but all of the methods suggested the presence of significant direct as well as
spillover effects in the data. The methods also agreed upon the fact that the effect of
treatment gets more pronounced over time. So, in accordance with previous studies, we
conclude that vaccination has direct as well as indirect effect on the incidence of cholera
in a particular neighborhood. Keeping everything else fixed, more vaccination should
yield a lower number of cholera infections in a region.
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APPENDIX A: TECHNICAL DETAILS FOR CHAPTER 2
Proof of proposition 1. From the definition of the IPCW estimator,




π(Ai,−j;α)I(Aij = a)I(∆ij = 1)I(Xij ≤ t)
Pr(∆ij = 1|Li, Xij) Pr(Ai|Li)ni
}
(1)






π(Ai,−j;α)I(Aij = a)I{Cij > Tij(Ai)}I(Tij(Ai) ≤ t)
Pr{Cij > Tij(Ai)|Li, Tij(Ai)}Pr(Ai|Li)ni
]
Moving the inner expectation inside the summation and taking out terms that are
constant with respect to that expectation, it follows that
E{F̂i(t, a, α)} = ETij(Ai),Ai,Li
[∑ni
j=1 π(Ai,−j;α)I(Aij = a)I{Tij(Ai) ≤ t}
Pr(Ai|Li)ni
×
ECij |Tij(Ai),Ai,LiI{Cij > Tij(Ai)}
Pr{Cij > Tij(Ai)|Li, Tij(Ai)}
] (2)
Next note that Assumption III implies that Cij ⊥ {Tij(Ai),Ai}|Li, which implies Cij ⊥
Ai|{Tij(Ai),Li}. Therefore,
ECij |Tij(Ai),Ai,LiI{Cij > Tij(Ai)} = ECij |Tij(Ai),LiI{Cij > Tij(Ai)}
= Pr{Cij > Tij(Ai)|Li, Tij(Ai)}
implying (2) simplifies to
E{F̂i(t, a, α)} = ETij(Ai),Ai,Li
[∑ni





Then, as in Tchetgen Tchetgen and VanderWeele (2012), it follows that
E{F̂i(t, a, α)} = ETi(.),LiEAi|Ti(.),Li
[∑ni










π(s;α)I{Tij(aij = a, ai,−j = s) ≤ t}×
{
Pr(Aij = a,Ai,−j = s|Ti(.),Li)
Pr(Aij = a,Ai,−j = s|Li)
}]
By assumption I, Pr(Aij = a,Ai,−j = s|Ti(.),Li) = Pr(Aij = a,Ai,−j = s|Li). Therefore





π(s;α)I{Tij(aij = a, ai,−j = s) ≤ t}

= E{F̄i(t, a, α)} = µ(t, a, α).
A similar proof can be used to show E{µ̂(t, α)} = µ(t, α).
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APPENDIX B: TECHNICAL DETAILS FOR CHAPTER 3
Proof of proposition 2. According to the definition of the parametric g estimator







Pr(Tij ≤ t|Lij, A = a,Ai,−j = ai,−k,ω)π(ai,−j, α)
Using causal consistency,
Pr(Tij ≤ t|Li, A = a,Ai,−j = ai,−j,ω)
= Pr(Tij(a, ai,−j) ≤ t|Li, A = a,Ai,−j = ai,−j,ω)
Then, using the conditional independence assumption,
Pr(Tij(a, ai,−k) ≤ t|Li, A = a,Ai,−j = ai,−j,ω) = Pr(Tij(a, ai,−j) ≤ t|Li,ω)
= ETi(.)|LiI(Tij(a, ai,−k) ≤ t)
So,























I(Tij(a, ai,−k) ≤ t)π(ai,−j, α)
= µ(t, a, α)
Hence,
E{minti (t, a, α,ω)} = µ(t, a, α)
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Similar calculations will yield
E{minti (t, α,ω)} = µ(t, α)
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APPENDIX C: TECHNICAL DETAILS FOR CHAPTER 4
Proof of proposition 3. Assume β∗, γ∗, and ω∗ to be such that
E{ψck(Xi,∆i,Li,γ∗)} = E{ψxk(Ai,Li,β∗)} = E{ψORck (Xi,∆i,Li,ω∗)} = 0 where
the expectation is taken over the true parameter values. The following proof shows
that E(ψDRaα (Oi,θDR∗)) = 0 when either ω∗ = ω0 or β∗ = β0 and γ∗ = γ0 where









ij = 1){I(Xij ≤ t)−mij(Ai, t,Li,ω∗)}π(Ai,−j;α)







Using the law of total expectation and taking out terms that are constant with respect






[I(Aij = a){I(Tij(Ai) ≤ t)−mij(Ai, t,Li,ω∗)}π(Ai,−j;α)
Pr(Ai|Li,β∗)
×
ECij |Tij(Ai),Ai,LiI{Cij > T
t
ij(Ai)}











Correct treatment and censoring models
Note that Assumption III implies that Cij ⊥ {Tij(Ai),Ai}|Li, which implies Cij ⊥
Ai|{Tij(Ai),Li}. If γ∗ = γ0 then
ECij |Tij(Ai),Ai,LiI{Cij > T
t
ij(Ai)}




ECij |T tij(Ai),Ai,LiI{Cij > T
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ij(Ai)} = ECij |Tij(Ai),LiI{Cij > Tij(Ai)}
= Pr{Cij > T tij(Ai)|Li, Tij(Ai), γ0}
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π(s;α)I {Tij(aij = a, ai,−j = s) ≤ t}
)
= µ(t, a, α)
So, E(ψDRaα (Oi,θDR∗)) = 0 when β∗ = β0 and γ∗ = γ0.
Correct outcome model






[I(Aij = a){I(Tij(Ai) ≤ t)−mij(Ai, t,Li,ω∗)}π(Ai,−j;α)
Pr(Ai|Li,β∗)
×
Pr{Cij > T tij(Ai)|Li,γ0}


























Pr(Aij = a,Ai,−j = s|Li,β0)
Pr(Aij = a,Ai,−j = s|Li,β∗)
}
×
Pr{Cij > T tij(Ai)|Li,γ0}











If ω∗ = ω0 then mij(a, s, t,Li,ω∗) = ETi(.)|Li {I {Tij(aij = a, ai,−j = s) ≤ t}}. So, the
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 = µ(t, a, α)
So, E(ψDRaα (Oi,θDR∗)) = 0 when ω∗ = ω0 or when β∗ = β0 and γ∗ = γ0. By
M-estimation theory (Stefanski and Boos 2002),
√
m(θ̂ − θDR∗) converges in dis-
tribution to a normal distribution with mean 0 and covariance matrix ΣDR equal
to U(θDR∗)−1V (θDR∗){U(θDR∗)−1}T where U(θDR∗) = E{−ψ̇(Oi,θ)}, V (θDR∗) =
E{ψ(Oi,θDR∗)ψ(Oi,θDR∗)T}, and ψ̇(Oi,θ) = ∂ψ(Oi,θ)/∂θT when ω∗ = ω0 or when
β∗ = β0 and γ∗ = γ0. Consistency and asymptotic normality of the direct, indirect and
total effect estimators follows from the delta method. Similar techniques can be used to
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